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“It ain’t over ‘til the fat lady sings” 
                                                  - Unknown philosopher
  
ABSTRACT 
Aim: The overarching aims of this thesis were to: evaluate the psychometric properties of a 
new clinical balance tool in People with Parkinson’s disease (PwPD) with mild to moderate 
disease severity; as well as to investigate the effects of a new gait and balance training 
regime, developed to target specific symptoms commonly observed in this population. 
Methods: Paper one entailed the evaluation of a balance tool’s (the Mini-BESTest) 
reproducibility in a clinical context, when used in PwPD. In order to investigate how the 
reproducibility was affected by different administrators, 27 PwPD performed the Mini-
BESTest with two physiotherapists who administered the test separately. In order to evaluate 
how the reproducibility was affected between test occasions, the participants returned 7 days 
later to be reassessed by one of the physiotherapists. Paper two entailed the evaluation of the 
Mini-BESTest’s validity by means of hypotheses testing, which included, for example, the 
test’s ability to distinguish between PwPD and healthy controls; and between PwPD with 
mild and moderate severity. A total of 105 PwPD and 47 healthy controls participated in this 
evaluation. Papers III & IV evaluated, in form of a randomised controlled trial (RCT), if 
participation in 10-weeks of symptom-specific and challenging training affected gait and 
balance abilities, fall related concerns, physical activity and activities of daily living (ADL). 
In addition, the training effects on the abilities to walk while simultaneously performing an 
added task were also specifically addressed. One-hundred PwPD were recruited to this study 
and were randomised to either the training or control group (care as usual). 
Results: The reliability of the Mini-BESTest was found to be good. However the 
measurement error on individual level was considered high, reflecting more than 10 percent 
of the total score. When the agreement is related to a group level (in this case, 91 individuals), 
the measurement error only reflected 2 percent of the total score. Moreover, the Mini-
BESTest was able to adequately distinguish between PwPD and healthy controls, as well as 
between PwPD with mild and moderate disease severity, respectively. The findings from the 
RCT showed that the participants in the training group, when compared to the control group, 
improved balance, gait, ADL and showed tendencies towards increased physical activity, 
whereas fall related concerns were unaffected. During gait with an added task, the 
performance of the added task was improved while the gait remained unaffected. 
Conclusions: The psychometric properties of the Mini-BESTest make it appropriate for 
research purposes. Although the measurement error on individual level is considered large, 
the clinical value of the test is considered to exceed its flaws. Specific and challenging 
training can improve gait and balance abilities amongst PwPD, effects that might influence 
improved physical activity. Future research should investigate the importance of the added 
cognitive task when performed during gait.    
 
  
SAMMANFATTNING 
Syfte: Det övergripande syftet med denna avhandling var att undersöka skalegenskaperna hos 
ett nytt kliniskt balanstest hos personer med mild till måttlig grad av Parkinsons sjukdom 
(PS), likaledes var målet att utvärdera effekterna av ett nytt gång- och balansträningskoncept, 
specifikt utvecklat för denna population. 
Metod: Det första delarbetet bestod av utvärderingen av balanstestet Mini-BESTests 
reproducerbarhet då det används i klinisk miljö hos personer med Parkinsons sjukdom (PS).  
Tjugosju försökspersoner med PS deltog i studien. För att undersöka hur reproducerbarheten 
påverkades av olika fysioterapeuters bedömning utförde deltagarna Mini-BESTest under 
instruktion av två olika fysioterapeuter. För att även undersöka hur reproducerbarheten 
påverkades då testet utförs vid olika tillfällen, återkom deltagarna 7 dagar senare för att 
genomgå samma test med en av fysioterapeuterna. Delarbete två bestod av utvärderingen av 
Mini-BESTests validitet. Detta utfördes i form av hypotestester, bland annat rörande hur väl 
testet förmådde skilja mellan personer med PS och friska kontrollpersoner, samt mellan 
personer med olika grad av sjukdomen och olika fallhistorik. Till detta delarbete inkluderades 
105 personer med PS, samt 47 friska kontrollpersoner. De två avslutande delarbetena 
utvärderade, i form av en randomiserad kontrollerad studie, hur medverkan i 10 veckors 
symptomspecifik och utmanande träning påverkade gång och balansförmåga, fallrädsla, 
fysisk aktivitet och aktiviteter i dagliga livet. Likaså utfördes en specifik analys av förmågan 
att dela sin uppmärksamhet mellan gång och en kognitivt utmanande tilläggsuppgift. Till 
denna studie rekryterades 100 personer med PS, vilka randomiserades till att ingå i en 
träningsgrupp respektive en kontrollgrupp (sedvanlig behandling). 
Resultat: Balanstestet Mini-BESTest påvisade god reliabilitet, dock motsvarade mätfelet på 
individnivå drygt 10 procent av testets totalpoäng, vilket ansågs högt. Då mätfelet anpassades 
till gruppnivå (91 individer) motsvarade det dock mindre än två procent av totalpoängen. 
Vidare förmådde Mini-BESTest skilja mellan personer med PS och friska kontroller, liksom 
mellan personer med mild respektive måttlig grad av PS. Resultatet från den randomiserade 
kontrollerade studien visade att deltagarna i kontrollgruppen, i jämförelse med 
kontrollgruppen, förbättrade sin gång och balansförmåga. Tillika resulterade träningen i 
förbättrad förmåga att utföra aktiviteter i dagliga livet samt tendenser till ökad fysisk aktivitet, 
däremot påverkades inte fallrädslan. Under gång med en kognitiv tilläggsuppgift, förbättrades 
utförandet av den kognitiva uppgiften hos träningsgruppen, gångförmågan förblev dock 
oförändrad. 
Konklusion: Mini-BESTests skalegenskaper på gruppnivå gör testet lämpligt att använda vid 
forskning. Mätfelet på individnivå bedöms vara stort. Detta till trots bedöms testets kliniska 
värde överstiga dess tillkortakommanden. Specifik och utmanade träning kan förbättra gång 
och balansförmågan hos personer med mild till måttlig PS, effekter som dessutom visar 
tendenser till ökad aktivitetsnivå i dagliga livet. Framtida studier bör undersöka vikten av den 
kognitiva uppgiften då den utförs simultant med gång.    
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1 INTRODUCTION 
 
The maintenance of gait and balance functions is crucial for physical independence and 
successful aging in general, and in particular, the self-perceived quality of life of people with 
Parkinson’s disease (PwPD).1,2 Hence, the overarching theme of this thesis was the 
investigation of the effects of a new gait and balance training regime in PwPD, aimed at 
targeting related functioning problems. However, in order for conclusions to be valid in 
medical research, one needs to be able to rely upon the measurements used.   
This thesis was divided into two parts. The first, psychometric part, constitutes the 
investigations of the psychometric properties of a clinical balance instrument (The Mini-
BESTest) stated to measure the construct of dynamic balance. The second, intervention part, 
investigated the effects of a new gait and balance training regime (The HiBalance 
programme)
3
 with regard to the following: (1) the overall gait and balance performance; and 
(2) the automaticity of gait and a simultaneously performed cognitive task.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
2 BACKGROUND 
 
2.1 PARKINSON’S DISEASE 
2.1.1 Prevalance and pathophysiology 
Parkinson’s disease (PD) is the world’s second most common neurodegenerative disorder. 
Although hereditary and environmental factors account for a slightly increased risk of 
diagnosis, the aetiology of PD remains largely unknown.
4,5
 The estimated prevalence of PD is 
5 million cases worldwide and 22 000 in Sweden. 
4,6
 Although PD also occurs at younger 
ages, the disease is most commonly diagnosed after the age of 60.
4
 With the increased life 
expectancy worldwide it is estimated that approximately 9 million people will be diagnosed 
with PD in the next 15 years.
7
  
The pathophysiology in PD is rather complex, however, a simplistic description of the main 
characteristic is the progressive process of neuronal degeneration in the substantia nigra pars 
compacta.
8
 This leads to a substantial loss of dopaminergic neurons in the nigrostriatal 
pathway and, eventually, the basal ganglia. The major cause of the motor symptoms 
occurring in PwPD is related to this neuronal loss.
9,10
  
 
2.1.2 Clinical manifestations, diagnosis and disease severity 
The main clinical manifestations observed in PwPD are the cardinal motor symptoms: 
tremor; bradykinesia; rigidity; and postural instability.
11
 Other common motor features 
include but are not limited to: impaired gait; speech impairments; dysphagia; and reduced 
facial expressions. In addition to the well documented motor symptoms, PD is also 
accompanied by a variety of non-motor symptoms.
12
  These include the prevalence of 
cognitive impairments such as executive dysfunction.
13
 Other common non-motor symptoms 
are impairments of the autonomic system, gastrointestinal disturbances, sensory symptoms, 
sleep disorders and neuropsychiatric symptoms, including depression.
14
    
There is no definite test to diagnose PD. Hence, clinicians tend to base their conclusions upon 
the presence of a combination of the above-mentioned cardinal symptoms, and the response 
to Levodopa medication (i.e. the first hand treatment for PwPD).
15
  It is possible, however, 
that, the clinical characteristics may overlap between PD and other Parkinsonian subtypes, 
which may alter the primary diagnosis; therefore the diagnosis may change with time if 
certain symptom patterns related to the progression of the disease are absent. 
 
 
  3 
Since PD is a progressive disorder -meaning that symptoms tend to increase with time -the 
healthcare management of it may differ depending on the stage of the disease. One 
commonly used scale to categorise PwPD with regard to their severity of motor symptoms is 
the Hoehn and Yahr scale (H&Y).
16
 This scale ranges from one to five, where a higher H&Y 
score signifies a more severe disease stage (Table I).  
Table I. The Hoehn & Yahr Scale 
1. Unilateral involvement only, usually with minimal or no functional disability 
2. Bilateral or midline involvement without impaired balance 
3. Bilateral disease, mild to moderate disability with impaired postural reactions  
4. Severe disability, ability to walk or stand without assistance 
5. Restricted to bed or wheelchair,  Assistance required for mobility  
 
2.1.3 Effects of Parkinson’s disease on everyday life 
Among the symptoms observed in PwPD that have the most detrimental effects on health 
related quality of life are gait and balance impairments.
2
 Indeed, up to 70 percent of PwPD 
fall every year and out of these, 40 percent fall multiple times.
17,18
 Impaired gait and balance 
abilities are among the major contributors to increased fall risk
19
, and are related to fall-
related concerns as well as activity limitations.
2,20
 Therefore such impairments may interfere 
with participation in daily life.
2
 
 
2.2 GAIT AND BALANCE CONTROL 
Within this thesis continuous steady state gait during less-demanding conditions and transient 
task-specific gait (for example negotiating obstacles and performing sudden turns) will be 
treated as two different constructs.
21,22
 Operationally, the former and latter will be referred to 
as ‘gait’ and as ‘dynamic gait’, respectively throughout the thesis.  
Gait refers to steady state gait during over-ground walking conditions and entails the detailed 
investigation of the overall performance of numerous repeated steps.  
Dynamic gait entails the ability to perform specific tasks while walking and relies upon 
adaptability to the demands of those specific tasks. It is clinically evaluated with regards to 
the overall performance of different gait-specific tasks, and is considered to be related to the 
multi-dimensional construct of balance control.
23
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2.2.1 Gait 
Gait is fundamental for a physically independent lifestyle, and is a strong predictor of overall 
health status.
24-27
 Although walking may appear as a simple task, the recent description of a 
supraspinal locomotor network and its complex interactions highlights the complexity of 
gait.
28,29
 Considering that PwPD exhibit deviant activity in all structures related to this 
network,
22
 it is unsurprising that gait impairments is one of the main disabilities found in this 
population. Indeed,  PwPD have been shown to walk slowly, with short, narrow, variable and 
asymmetric steps, compared to healthy people.
22
 
The importance of investigating different gait parameters in PwPD can perhaps be 
highlighted by relating different aspects of gait impairments to common symptoms and their 
related structural characteristics. The slowness of gait, for example, may be related 
bradykinesia and/or rigidity.
22
 These symptoms have been suggested to be caused by reduced 
excitability of cortical motor areas;
30
 and impaired interactions between the basal ganglia and 
deep brain structures,
31
 respectively. Moreover, whereas gait asymmetry among PwPD is 
likely related to the unilateral onset of the disease (and suggested to depend upon the 
asymmetric dysfunction of the basal ganglia),
32
 gait variability (i.e. the step to step 
fluctuations) has no clear cut structural explanation.
22
 Nevertheless, gait variability has been 
promoted as a particularly important characteristic with the potential to predict falls.
33,34
  
Taken together, it is unsurprising that different aspects of gait have been thoroughly 
investigated over the years. On the other hand, a lack of unity regarding which gait 
parameters to investigate and what they represent has made it difficult to compare results 
across studies.
35
 However, in recent years efforts have been made to identify discrete 
parameters related to independent domains of gait.
36,37
 Each of these domains is theorised to 
contain important information regarding specific aspects of gait, while at the same time 
combine to represent the multidimensional construct of human gait.  
One of these models has been validated for PwPD
35
 and encompasses the following domains: 
Pace; Rhythm; Variability; Asymmetry and Postural Control (Figure 1). Indeed, in 
comparison to healthy controls, PwPD have shown impairments related to all of these 
domains.
22
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Figure 1. An illustration of the independent domains of gait and its related parameters, 
theorised to represent the multi-dimensional construct of gait.
37
  
 
2.2.1.1 The concept of automaticity 
Gait has for a long time been considered an automatic activity in healthy people.
38
 The notion 
of gait automaticity is that it requires minimal attention, which instead can be directed 
elsewhere.
39
 Automatic gait may be highly relevant for everyday life, especially when 
performing tasks or actions within a particular context such as when a person is crossing a 
street. Indeed, if this person would then be preoccupied by paying attention to the gait 
performance, he or she may not be able to detect potential hazards, such as approaching 
vehicles, curbs or other pedestrians. 
 
2.2.1.2 Automatic versus controlled processing 
The concept of automaticity relies upon the framework by Schneider and Shiffrin,
40
 and has 
its theoretical roots within the cognitive research field (but has since been adopted by the 
locomotor research field).
39
 This framework distinguishes between automatic and controlled 
processing.
41
 Automatic processing was defined as “the activation of a sequence of nodes that 
nearly always becomes active as a response to a particular input configuration”, and that is 
“activated automatically without the necessity for active control or attention by the subject”. 
Controlled processing, on the other hand, was defined as “a temporary set of nodes that are 
 6 
activated under control of, and through attention, by the subject”. Whereas the automatic 
processing relies upon and require an appreciable amount of training to fully develop, 
controlled processing has the benefit of being applied in novel situations.
41
 By translating this 
to activities, motor or cognitive, these two types of processing may be interpreted to 
complement each other. When sufficient amount of training have led to automatic processing, 
a task may be optimally performed with minimal attention, which instead can be allocated to 
a novel (or untrained) task which requires attention.   
 
2.2.1.3 The dual-task paradigm  
The most common way of investigating automaticity is by means of the dual-task (DT) 
paradigm.
42
 This paradigm entails the concurrent performance of two tasks with distinct 
objectives. Each of these tasks is also performed separately, that is, as single-tasks (ST). From 
this, the difference in task-performance under DT and ST-conditions, termed DT-interference 
(DTI) could be approximated, which is considered an estimation of the degree of 
automaticity.
39
 Moreover, the DTI can be presented as an absolute value (by subtracting the 
ST performance from the DT performance of the same task) or a relative value (by dividing 
the absolute DTI with the ST-performance).
43,44
 
In addition to measuring automaticity, the DT-paradigm can also be used to assess DT-
abilities per se, that is, without taking the ST-performance into account. Whereas the DTI is a 
relative measure, considered to represent automaticity; the absolute measures of DT-abilities 
can be considered to represent the abilities to perform certain tasks under dual-processing.      
Within the field of gait research, the DT-paradigm refers to the examination of gait 
performance in combination with an added task. This added task may be of a more manual 
(for example, manipulating buttons) or cognitive character (such as counting backwards by 
3s). However, in recent years cognitive tasks have been more commonly used, due to the 
increased understanding of the impact that executive functions may have on gait.
38
  
 
2.2.1.4 Executive functions 
Executive functions are defined as a set of cognitive processes that control goal-directed 
behaviours.
13
 These processes have been found to have great impact on DT abilities. One of 
the prevailing models used to conceptualise the role of executive functions and its impact on 
automaticity and attention, is the supervisory attentional system model.
45
 This model suggests 
that two basic tasks can be performed simultaneously without interference as long as they are 
automatic, whereas more advanced, non-automatic tasks need conscious attention that is 
coordinated from the supervisory attentional system. Relating this model to neurophysiology, 
it is widely accepted that the basal ganglia is responsible for automaticity, whereas the role of 
the prefrontal cortex is coinciding with that of the supervisory attentional system.
13
   
  7 
2.2.1.5 Structural impact on automaticity in people with Parkinson’s disease 
PwPD frequently exhibit impaired automaticity of both motor and executive functions.
13,39,46
 
This is believed to be due to the basal ganglia dysfunction in this population, which in turn 
leads to a dependency of cortical attention (i.e. the supervisory attentional system) even for 
the performance of basic tasks ( which are automatic in healthy people).
13
 In addition, it has 
also been suggested that impaired motor automaticity in PwPD is related to impairments of 
the sensorimotor striatum, a structure that is responsible for automatic motor programming in 
healthy people.
46
 This in turn suggests that PwPD need to rely upon controlled processing 
(which is limited in its capacity)
41
 even for single-tasks. Hence, during DT-conditions, there 
might be a competition for attention, which may highlight the importance of prioritisation 
strategies among PwPD.  
 
2.2.1.6 Prioritisation strategies during dual-task conditions 
The concept of task prioritisation during DT-conditions refers to the idea that attention will be 
allocated to the “most important” task. Prioritisation strategies are commonly investigated by 
comparing the DTI of the two concurrently performed tasks, where the task with the least 
interference is considered to be prioritised.
44
 
For a long time, the common comprehension was that a sound prioritisation strategy was to 
use the posture first strategy.
47
 The idea of this strategy is that healthy people will always 
prioritise the motor task (for example gait or balance), rather than the added cognitive task 
during DT-conditions. PwPD on the other hand, have been considered to use the supposedly 
deviating posture second strategy during DT-conditions.
48
 Although this may be true, recent 
evidence suggests that similar strategies are used by healthy people.
49
 Moreover, two studies 
that investigated the abilities to actively allocate attention to either gait or the added task 
found similar patterns among PwPD and healthy people.
50,51
  
Based on this, a new model of task prioritisation has emerged.
49
 According to this model, task 
prioritisation during DT-conditions depends upon a balance between postural threat and 
postural reserves as perceived by the subject. The first, postural threat, refers to the 
perceived hazard of the task at hand, such as the risk of injury; and the second, postural 
reserves, refers to the physical abilities of the individual, for example gait and balance 
abilities. Moreover, this model states that healthy people, with sufficient postural reserves, 
will always prioritise the added cognitive task if the motor task is perceived to be of low 
threat. Conversely, a person with limited postural reserves will prioritise the motor task if the 
added task becomes too demanding, thereby competing for attentional resources. It may be 
interpreted that this model highlights the importance of the perceived difficulty level of either 
task, in relation to the individual’s capacities.  
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2.2.1.7 Relation between dual-task deficiencies and falling 
Both impaired automaticity and absolute DT-gait abilities have been related to increased risk 
of falling in elderly people.
52
 Moreover, although single-task gait speed is an important 
indicator of overall health and survival, a recent review found that dual-task gait performance  
had an added value with regards to fall-prediction.
52
 This review also recommended future 
studies to analyse the impact of the added task and the DTI of gait performance with regards 
to the future risk of falling.   
 
2.2.2 Balance control 
Balance control has been defined as a complex motor skill dependent upon the interaction 
multiple sensorimotor processes, with main functional goal of postural equilibrium and 
postural orientation.
53
 Postural equilibrium (or stability) refers to the control of Centre of 
Mass (CoM) in relation to the Base of Support (BoS). Postural orientation refers to the active 
maintenance of an adequate posture and depends upon gravity, visual environment, support 
surface and internal references.
53
 
Balance control is a prerequisite for the performance of a variety of activities. In humans 
these activities have been classified into three overarching categories: (1) the maintenance of 
a specific posture, for example sitting or standing; (2) voluntary movements, for example 
movements between postures; and (3) the reaction to an external disturbance, such as a trip, a 
slip, or a push.
54
 
Relying upon the notion that balance control relies upon a set of different underlying 
systems,
55
 Horak et al. recently presented a model for balance control.
23
 This model 
encompasses six underlying domains, thought to represent the multidimensional construct of 
balance (Figure 2).  
  9 
 
Figure 2. An illustration of Horak’s model for balance control.23  
 
2.2.2.1 Biomechanical constraints 
Biomechanical constraints refer to constraints arising from the individual’s biomechanical 
system, which may alter balance abilities. In PwPD, common biomechanical constraints are 
related to symptoms such as reduced lower limb joint torques, flexed spinal abnormalities and 
stooped posture.
56,57
  
 
2.2.2.2 Stability limits 
Stability limits refer to the relation between the CoM and the BoS. Generally, if the CoM 
falls outside of the BoS, an object or a person lose the control of balance.
54
 Hence, the area 
making up the BoS may therefore be considered the theoretical stability area (i.e. the limits of 
stability).
58
 Moreover, in clinical balance assessments, stability limits may be defined as the 
maximum possible displacement of the body’s CoM without the necessity of taking a step, or 
worse, falling.
59
 This is commonly assessed with regard to an individual’s voluntarily 
inclined posture, which in addition to body biomechanics and segment properties, is affected 
by subjective and environmental factors.
58,59
 As such, clinical assessments may be assessing 
the functional limits of stability, which might differ from the limits of stability.
58
 In this 
thesis, stability limits refer to the functional limits of stability. 
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From an early disease stage, PwPD demonstrate impaired stability limits when compared to 
healthy people, with particularly pronounced deficiencies in the backwards direction.
59
 
Indeed, it has been proposed that the stooped posture in PwPD, resulting in a forward 
projection of the CoM, may be the results of a compensatory strategy, protecting them against 
backwards falling.
22,60
   
 
2.2.2.3 Anticipatory postural adjustments 
Anticipatory postural adjustments (APAs) refer to the onset of postural changes (for example 
activation of postural muscles) that occur prior to a self-initiated balance perturbation.
61
  The 
APAs are affected by three main factors: (1) the expected magnitude and direction of the 
perturbation; (2) the voluntary action associated with the perturbation; and (3) the postural 
task.
62
 For example, starting to walk from a standing position will be preceded by different 
APAs than when rising up to standing from a seated position, or when lifting a heavy 
suitcase.  
People with PD have demonstrated slower APAs of smaller magnitude when compared to 
healthy people, which has been related to the cardinal symptom bradykinesia. Moreover, the 
deviant APAs in this population have also been found to be asymmetric
63
 and variable.
64
 
Taken together, these findings have been implied to play a part in the delayed step initiation 
and freezing of gait among PwPD.
63-66
 
 
2.2.2.4 Postural responses 
Postural responses refer to the ability to respond to a sudden external perturbation (such as a 
trip, slip or push) that position CoM outside of the BoS. Therefore, adequate postural 
responses may be considered the ultimate attribute for the avoidance of falling. Postural 
responses are considered to be automatic, however they differ from spinal reflexes in the 
sense that the latter occur at shorter latencies, indicating different neural pathways.
67-69
 
Although the brainstem’s involvement in the generation of postural responses is undisputed at 
large, recent findings suggest that the interaction between the basal ganglia and the cortex 
plays a role.
22,69-72
 In addition, it has also been suggested that the neural circuitry may differ 
between postural responses in different directions.
72
   
Taken together, this may suggest why PwPD show impaired postural responses at an early 
disease stage,
73,74
 and perhaps also why impairments of postural responses in the backwards 
direction appear to be particularly pronounced in this population.
75-78
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2.2.2.5 Sensory orientation 
Sensory orientation (or sensory integration) refers to the ability of using sensory information 
to generate adequate motor responses (such as stabilising the body) within the context of the 
current environmental challenges. This occurs through the central nervous system, where the 
respective information from the visual, vestibular and proprioceptive systems are integrated 
and weighed.
79
 Moreover, this integration process is adaptive, meaning that the input from 
the different systems will have different impact depending on the situation.
80
 
One common way to measure sensory orientation is by analysing, for example, the frequency 
and amplitude of body sway (i.e. the continuous movements of the CoM) during upright 
standing (with the feet in fixed positions). Increased body sway is then generally interpreted 
as challenges with the integration of sensory information, and tend to increase when visual 
input is restricted or when an individual stand on unstable surfaces. 
PwPD exhibit a variety of somatosensory impairments, including tactile, thermal, 
proprioceptive, and nociceptive disturbances.
81
 Such disturbances may combine to produce 
incorrect integration in the central nervous system, leading to impaired signalling necessary 
for the preparation and execution of motor responses. This may be an explanation to deviant 
postural behaviours among PwPD (in comparison to healthy people); such as exaggerated 
body sway, which, in turn, become particularly pronounced when visual input is 
restricted.
82,83
 The latter finding has been attributed to an over-dependency of visual input, in 
particular considered to compensate for impaired proprioception in this population. Although, 
this visual dependency is important in its own right, it may be particularly detrimental when 
considering that PwPD are at risk of developing a variety of visual impairments throughout 
the course of the disease.
82
  
 
2.2.2.6 Stability in gait 
Stability in gait (or dynamic gait) refers to context specific adaptability during gait. This may 
include the ability to perform a sudden turn while walking (for example to avoid an 
approaching obstacle), the need to suddenly increase or decrease the walking speed (for 
example during a road crossing, before the traffic light changes) or lift the foot to clear an 
obstacle. 
PwPD have difficulties adapting their gait.
84-86
  This may contribute to the fact that PwPD 
experience falls during common everyday life situations that require the ability to adapt gait, 
for example during turning while walking.
74,87
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2.3 TREATMENT OF GAIT AND BALANCE IMPAIRMENTS  
The treatment of gait and balance impairments in PwPD is recommended to include a 
combination of levodopa medication and training.
88
 This is partly due to uncertainties 
regarding the effects of levodopa on certain aspects of gait and balance,
89,90
 in combination 
with increasing evidence supporting the impact of training.
91-93
 
 
2.3.1 Effects of levodopa on gait and balance control  
The first hand treatment for PwPD is levodopa medication. In fact, responsiveness to this sort 
of medication has traditionally been a prerequisite to be diagnosed with idiopathic PD.
11
 
However, levodopa has mixed effects on gait and balance abilities.
89,90
 Indeed, while 
levodopa appears to have a moderately beneficial effect on gait measures related to 
bradykinesia such as step velocity and step length during gait, it does not appear to affect gait 
measures related to rhythmicity, such as swing or stance time.
89
 With regards to balance, 
small improvements were shown with regards to APAs, whereas sensory orientation 
(measured as postural sway) actually worsened with levodopa treatment.
89
 In order to address 
these balance deficiencies, training interventions may prove highly important as a 
complement to levodopa treatment. 
 
2.3.2 Effects of training 
Up until recently, it was cast in doubt whether or not training interventions would prove 
beneficial with regards to, among others, gait and balance impairments in PwPD.
94
 However, 
in the past few years, an increasing number of studies on this issue have contributed to the 
general perception that training can indeed prove beneficial for PwPD. 
88,92,93,95
 More 
specifically, recent findings suggest that training can improve functional outcomes as well as 
induce neuroplasticity and be neuroprotective in PwPD.
91,96,97
 
 
2.3.2.1 Training effects on plasticity and neuroprotection    
Recent evidence from animal models
98-100
 as well as PwPD
101-106
 suggests that exercise may 
have the potential to induce neuroplasticity and neuroprotection in this population. Findings 
range from increased cortical excitability
101
 (which is related to, for example, the slowness of 
gait in PwPD)
22
 to improved neurotrophic factors (suggested to reduce cell death, hence is 
considered to be neuroprotective).
91,103-105
 Moreover, although most of the findings are related 
to high intensity aerobic exercises,
101,102,105
 one study found that six weeks of balance 
training, consisting of one 45-minute session per week, induced grey matter changes in the 
parietal basal ganglia circuitry.
106
 This may be highly relevant since this is an area that have 
been related to impaired automaticity in PwPD.
91
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2.3.2.2 Training effects on single task gait 
Previous findings on ST-gait improvements following training in PwPD generally refer to 
improved gait speed, whereas for example, improved step length is more rare to achieve.
93
  
Nevertheless one training programme that compared extensive walking over six weeks, with 
Nordic walking and placebo training, found that both walking groups improved step length 
and step length variability in comparison to the placebo group.
107
 These improvements were 
significantly larger in the Nordic walking group, as compared to the walking group. The 
authors argued that it was due to higher intensity walking in the Nordic walking group, which 
may indicate that ST-gait in PwPD might benefit from prolonged exposure to gait at higher 
intensity (or challenge) levels.  
 
2.3.2.3 Training effects on automaticity and dual-task gait 
It was earlier questioned if PwPD were even able to improve automaticity and DT abilities. 
Rather, it was earlier advised against DT-gait training in this population since such training 
was considered to put PwPD at risk of adverse outcomes.
108
 However, it has since been 
shown that PwPD have the ability to obtain motor learning through DT-training, in fact their 
learning curves are similar to those of healthy people, albeit slower.
109
 This is a finding that 
has been supported by recent pilot studies. Specifically, those studies indicate that DT-
training can improve DT-gait abilities, 
110-116
 whereas the effects on ST-gait
112,116
 are more 
uncommon. This in turn may indicate the potential of improving both DT-gait abilities and 
gait automaticity among PwPD. On the other hand, few studies have found 
improvements
112,113
 on the added task, which is an area that has received little attention 
within this field.
117
 Nevertheless, the above mentioned findings remain to be confirmed 
through randomised controlled trials in order to guide clinicians whether or not to expose 
PwPD to DT-training. 
 
2.3.2.4 Training effect on balance control 
Findings from recent meta-analyses show that training interventions can improve balance 
control in PwPD.
93,118
 However, the diversity of studies make it difficult to convincingly pin-
point specific training characteristics related to improved balance control.
118,119
 Whereas the 
results from one of these studies indicate that highly challenging training may prove most 
beneficial for improving balance control among PwPD, it remains unclear to what extent 
specific balance tasks needs to be targeted.
118
 On the other hand, aerobic exercises alone were 
found to have limited effect on balance improvements. In addition, no evidence was found to 
support home-based multi-component training programmes that included balance exercises. 
These findings may indicate that training, in addition to be highly challenging, needs to 
incorporate balance exercises in order to improve balance control among PwPD. In line with 
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this, a recent recommendation suggests that training interventions in PwPD needs to 
emphasise intensity, specificity and complexity.
92
  
 
2.4 GAIT AND BALANCE ASSESSMENTS 
In order to enable adequate assessments of gait and balance abilities, as well as the effects of 
training, outcome measures (i.e. tests) need to be appropriate. This means that the results 
produced by each of these measures need to capture the phenomenon (or construct) that the 
measure purports to capture. Take the construct of balance control for example, it is 
important that the results produced by a test that is used to assess an individual’s balance 
control actually represents this individual’s current abilities pertaining to the construct. This 
means, for example, that the test needs to produce different results if the test is assessed in 
two individuals with different abilities of the investigated phenomenon, or in an individual 
with changed abilities between two test occasions (i.e. if balance control have become 
improved or worsened). Similarly, if the test is assessed in a single individual at different 
occasions, given that the individual’s abilities of this phenomenon has not changed between 
the occasions, the results produced by the test should not differ between the occasions (that is, 
the measurement error should be small).  
 
2.4.1 Assessment of gait and balance in laboratory versus clinical settings  
When investigating gait and balance abilities in research settings, advanced equipment is 
commonly used and tests are performed under highly controlled conditions. The assessment 
of gait for example, is commonly conducted by means of an electronic pathway or with 
sensors positioned at different segments of the subjects’ body (e.g. to assess foot patterns or 
joint angles),
120,121
 whereas balance control tends to be investigated by means of force plates 
(e.g. enabling the detailed analysis of body sway or APAs).
122
 Although such measurement 
conditions are indeed affected by, for example, instructions, their measurement properties 
may be argued to be relatively robust. Such measures may disclose highly important 
information
123
 but are rarely available in clinical settings, which may question its ecologic 
validity. Conversely, measures that are commonly used in clinical settings, and thereby have 
higher ecologic validity, tend to be more subjective in nature; hence, their measurement 
properties may lack robustness. Indeed, in clinical assessments, a variety of factors may threat 
the robustness of findings, not least related to the tester.
124,125
 In accordance with this, the 
measurement error found in many clinical tests can be considered quite high,
126-128
 often 
exceeding reasonable changes within treatment periods.
129-131
 Nevertheless, the importance of 
clinical tests is difficult to argue against due to their efficiency in providing information 
regarding a specific symptom (or construct). Indeed, should every patient need to be 
investigated in a laboratory setting, very few patients would be examined at all. This may 
emphasise the importance of thoroughly investigating the psychometric properties of clinical 
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tests. Such information can then be used by clinicians in order to interpret their findings; 
and/or by test developers to improve the tests.  
 
2.4.2 The Mini-Balance Evaluation Systems Test 
The Balance Evaluation Systems Test (BESTest)
23
 is a balance test that was based on 
Horak´s model of balance control, which relies upon the theory that the multidimensional 
construct of balance control encompasses six underlying domains (Figure 2); each of which 
should be investigated separately. The stated purpose with the BESTest was to enable 
clinicians to identify potentially deficient aspects of balance in patients, and direct treatment 
towards those domains. However, the BESTest was found too time consuming a test to use in 
clinical practice, since it was estimated to take around 30 to 40 minutes to administer. 
Therefore, the developers sought to develop a shorter, more clinically applicable version, 
which they named the Mini-Balance Evaluation Systems Test (the Mini-BESTest).
132
 This 
test had evolved from statistical analyses (i.e. Rasch and principal component analyses) and 
was stated to measure a unidimensional and undefined construct named dynamic 
balance.
132,133
 However, although this indicates that only the total score of the Mini-BESTest 
should be considered, the test clearly identified four underlying domains (APAs; postural 
responses; sensory orientation; and dynamic gait) and seemingly encouraged the sub scoring 
of these domains.
134
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2.5 PSYCHOMETRIC PROPERTIES 
Within this thesis, the psychometric properties of the Mini-BESTest will be investigated with 
regard to reproducibility and validity, as conceptualised and defined by the COSMIN 
taxonomy (Figure 3).
135
  
 
 
Figure 3. An illustration of the Cosmin taxonomy of psychometric properties.
135
  
 
 
2.5.1 Reproducibility 
Reproducibility concerns the degree to which repeated measurements in study objects 
provide similar results, and can be divided into parameters of reliability or agreement.
124
 
Whereas reliability measures aim to distinguish study objects from each other despite 
measurement errors; measures of agreement assess the absolute measurement error of a test 
(i.e., the exact measurement error, presented in the same units as the investigated 
item).
124,136
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2.5.1.1 Reliability 
Reliability is commonly investigated and reported by means of intra-class correlations (ICC), 
a measure that is highly dependent upon the variability in a sample (ICC= variability between 
subjects/ variability between subjects + measurement error).
125,137
 Since reliability measures 
aim to distinguish between subjects despite measurement errors, this means that if there is 
large variability between subjects, a larger measurement error will be accepted, and vice 
versa. Hence, the reliability measure is only generalisable to samples with similar 
variability.
124
 In addition, reliability measures have been proposed to be particularly 
important for assessment tools that are used for discriminative purposes, and less important 
for tools that are used for evaluative purposes.
138
 Nevertheless, the reliability measure may, 
arguably, be considered to measure if the sensitivity of the tool exceeds the measurement 
errors, a quality that may be important for research as well as clinical practice. 
   
2.5.1.2 Agreement 
Agreement is a measure considered to be neglected in medical research
124
; but that have been 
proposed to be important for assessment tools that are used for evaluative purposes
124,138
 
(such as effects of training). In addition, agreement can be calculated both on an individual 
level
139
 (that is, as the absolute measurement error of a single individual in the current 
population) and on a group level.
140
 
Agreement is calculated as the square root of the sample variance. This is interchangeably 
referred to as subject within or smallest error of measurement (SEM), in this thesis the term 
SEM will be used. Moreover, the SEM can either be calculated as SEMagreement (including 
systematic differences) or SEMconsistency (excluding systematic differences). Since systematic 
differences are likely to occur in clinical practice, particularly if different clinicians 
administer the same test at different occasions, SEMagreement is considered to increase the 
ecological validity and is therefore used within this thesis. Once the SEM is calculated, the 
Smallest Real Difference (SRD; also known as the smallest detectable change
140
 or minimal 
detectable difference) can be calculated with the formula: SRD=SEM x √2 x 1.96.139 This is 
considered the absolute measurement error on an individual level (SRDind) with a 95% 
confidence interval, hence is the score that needs to be exceeded in order to attribute potential 
changes to rehabilitation.        
In summary, reliability and agreement are considered to be important for discriminative and 
evaluative purposes, respectively. However, since both purposes may be of interest in a 
clinical assessment tool, it may be relevant to investigate both.  
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2.5.2 Validity 
The overall concept of validity refers to whether or not the result produced by an assessment 
tool is an adequate reflection of the construct that it intends to measure.
141,142
 
The three overarching categories of validity are content validity, criterion validity and 
construct validity. While the content validity is primarily investigated when developing a new 
instrument, the two latter categories are generally used to investigate the validity of existing 
instruments. Out of these two, criterion validity is regarded to be more powerful than 
construct validity, and can be assessed by means of concurrent or predictive validity. 
However, the definition of criterion validity is “the degree to which the scores of an 
instrument are an adequate reflection of a gold standard”.135 Hence, if no gold standard exists 
for the construct of interest, the criterion validity cannot be investigated. In such a case, a 
more preferable option is to investigate the construct validity.  
 
2.5.2.1 Construct validity 
Construct validity is defined as “the degree to which the scores produced by a measurement 
instrument are consistent with hypothesis”, for instance with regard to internal relationships, 
relationships with scores of other measurements or differences between relevant groups.
135
  
There are three existing categories of construct validity: structural validity, hypotheses 
testing, and cross-cultural validity. This thesis will focus on hypotheses testing. 
 
2.5.2.2 Hypotheses testing 
The basic principle of hypotheses testing is that hypotheses are formulated about expected 
differences between subgroups of patients (discriminative validity/known-groups validity) 
and/or expected relationships with measurement instruments evaluating related (convergent 
validity) or unrelated (divergent validity) constructs.
135
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2.6 RATIONALE 
Gait and balance disabilities are amongst the most debilitating impairments accompanying 
PwPD. Such symptoms have a major impact on the self-perceived quality of life and are 
related to increased fall frequency and activity limitations.
2,17-19
 However, recent evidence 
suggests that adequately designed training interventions (i.e. emphasising intensity, 
specificity and complexity, hence are highly challenging),
92,118
 have the potential to improve 
such symptoms. 
Inspired by Horak’s model of balance control, as well as by contemporary evidence with 
regard to motor learning and DT, we therefore developed the HiBalance programme. This 
procedure was conducted through workshops with clinicians and researchers, and resulted in 
four main balance components to be specifically addressed throughout the 10-week 
programme: Sensory orientation; APA’s; stability limits; and motor agility. Moreover, since 
this research field specifically identified a need for highly challenging balance training 
programmes,
92,118,143
 the exercises in the programme were to continuously evoke postural 
responses in order to ensure an adequate difficulty level. To further increase the challenge 
level, DT-exercises were introduced to the walking exercises during the mid-stage of the 
programme. Subsequently, the feasibility of the programme was investigated in a pilot 
study.
144
 This was followed by input from trainers and participants, which brought about 
minor modifications and resulted in the final study protocol.
3
 
Meanwhile, since balance control is best measured with a variety of balance tasks;
145
 the 
arrival of a new and promising clinical tool, encompassing multiple items corresponding to 
balance deficiencies commonly observed amongst PwPD, warranted the investigations of its 
psychometric properties when used in PwPD with mild to moderate disease severity.   
Therefore, this thesis is divided into two parts, where the first part investigates the Mini-
BESTest’s psychometric properties, with regard to reproducibility and construct validity, 
respectively. The second part constitutes the investigations of the effects of the HiBalance 
programme
3
 with regard to overall gait and balance performance, and the automaticity of gait 
and a simultaneously performed cognitive task.       
 
 
 
 
 
 
 
 20 
3 AIM 
 
The overall aim of this thesis was to, in elderly PwPD with mild to moderate disease severity, 
investigate the psychometric properties of a clinical balance tool as well as the effects of the 
HiBalance programme with regards to: overall gait and balance performance, automaticity, 
and attention allocation during dual-task conditions. 
 
 
3.1 SPECIFIC AIMS 
 
Paper I 
The aim was to investigate the inter-rater and test-retest reproducibility of the Mini-BESTest 
and its subcomponents in elderly with mild to moderate PD, under conditions similar to 
clinical practice.  
 
Paper II 
This paper aimed to investigate the Mini-BESTest’s construct validity by means of 
hypotheses testing, in PwPD with mild to moderate disease severity. 
 
Paper III 
The aim was to investigate the effects of a highly challenging training programme on overall 
gait and balance performance and fall-related concerns.    
 
Paper IV 
The aim was to investigate the effects of highly challenging training on automaticity and 
attention allocation in elderly with mild to moderate Parkinson’s disease.
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4 METHODS 
 
4.1 DESIGN 
Paper I: test-retest design. 
Paper II: cross-sectional design,  
Papers III & IV: a randomised controlled trial with a repeated measurements design 
 
4.2 RECRUITMENT 
Recruitment for the HiBalance programme was performed through advertisements in local 
newspapers; oral presentations at the Swedish Parkinson’s disease association; and outpatient 
neurological clinics.    
Participants that showed interest to participate in the HiBalance programme, and those 
subsequently called to baseline assessments were later contacted to participate in paper I. 
Conditional to their participation was that they had not performed the Mini-BESTest within 
the last two months. 
All participants that had been called to baseline assessments for potential participation in the 
HiBalance programme were asked for consent to use their results in paper II, given that they 
met the inclusion criteria. Figure 4 illustrates the recruitment of participants and sample sizes 
with regards to the respective papers.   
 
4.3 ETHICAL APPROVAL 
Ethical approval for these papers was obtained from the ethical board of ethics in Stockholm 
(Dnr: 2006/151-31; 2009/819-32; 2010/1472-32; 2011/1665-22; 2012-1829-32). These 
studies were conducted in accordance with the ethical principles for medical research 
involving human subjects, that is, the Helsinki declaration. Prior to entering the studies, all 
participants were informed of the purpose with each paper and that they would be able to 
withdraw at any time. In addition, the participants randomised to the control group were after 
the closure of the study offered to take part in the same training at the same facilities as had 
the training group. 
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Figure 4. Flowchart, an illustration of the recruitment procedure and the sample sizes for 
each respective paper in this thesis. 
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4.4 INCLUSION/EXCLUSION CRITERIA 
The inclusion criteria were: a clinical diagnosis of idiopathic PD;
146
 H &Y stages 2 or 3;
16
 ≥ 
60 years of age; the ability to independently ambulate indoors without a walking aid; ≥ 3 
weeks of unchanged dopaminergic medication; and observed signs of impaired gait or 
balance performance during the baseline assessments. The latter criterion was endorsed in 
an attempt to increase the ecological validity of the study, i.e. by including PwPD that 
would be considered for gait and balance training in clinical practice.   
The exclusion criteria were as follows: a mini-mental state examination (MMSE) score <24; 
other medical conditions affecting balance control; and/or other personal circumstances that 
might interfere with adherence to the study. 
Exceptions to inclusion criteria: Neither paper I nor paper II used observed signs of 
impaired gait or balance as an inclusion criterion. 
Exceptions to exclusion criteria: Paper I did not use an MMSE score as an exclusion 
criterion, in attempt to increase ecologic validity.   
 
4.5 SAMPLE SIZE ESTIMATIONS 
Paper I: The sample sizes estimations were based upon the sample sizes of similar studies 
investigating the psychometric properties of the Mini-BESTest, which a typical range of 
between fifteen and thirty-two participants.
127,128,133,147
 Despite initially aiming to include 
thirty-five PwPD, we ended up with twenty-seven due to late drop-outs and time 
constraints.    
Paper II: The sample size estimations used in this study were based upon the Cosmin 
recommendations, for hypotheses testing.
148
 Here a sample of at least one-hundred 
participants is considered excellent, and a sample of fifty is considered to be good. Keeping 
with the recommendation for excellence, one-hundred and five PwPD with a mild to 
moderate disease severity were included. However, for the recruitment of healthy control 
subjects, we aimed to include fifty people but had to settle with forty-seven included 
subjects.   
Papers III & IV: The sample size estimations were based upon a pilot study on the training 
programme
144
 as well as similar studies in PwPD.
114,149
 Power (80% at a 5% alpha-level) was 
calculated for three outcomes: the Mini-BESTest; DTI of gait velocity; and the falls efficacy 
scale (FES-I). With an estimated dropout rate of 15%, and corrections for long term follow-
up (not included in this thesis), a sample size of one-hundred PwPD was recommended (i.e. 
fifty PwPD per group). Hence, one-hundred PwPD were included. 
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4.6 PARTICIPANTS 
The demographic characteristics of the participants in each paper are summarised in Table II. 
 
4.7 ASSESSMENT TOOLS 
A variety of assessment tools were used in this thesis, both as descriptors and as outcome 
measures. Table III summarises the tools used for each respective paper. 
 
4.7.1 The Mini-BESTest 
The Mini-BESTest
132
 is a clinical tool, stated to measure dynamic balance. This test 
encompasses 14 items, divided into the four subcomponents: anticipatory postural 
adjustments, postural responses, sensory orientation, and dynamic gait. Items are scored 
from 0 (unable or requiring help) to 2 (normal) on an ordinal scale, with a maximal total 
score of 28 points. In accordance with recommendations,
134
 the items single limb stance 
and compensatory stepping correction (lateral) were assessed for both the right and left 
sides, albeit only the score of the worst side was used to calculate the total score. The items 
of the Mini-BESTest are presented in Table IV. 
Within this thesis, The Mini-BESTest- both its total score and subcomponent scores - is an 
outcome measure in papers I, II and III. 
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Table II. Participant characteristics with regards to the respective papers included in this thesis. 
 
n 
Mild/ 
Moderate (%) 
Male/ 
female (%) Age (years) UPDRS, motor Time since diagnosis (years) 
     
Mean (SD) Range
 
Mean (SD) Range
 
Mean (SD) Range
 
Paper I       
PwPD 27 59/41 67/33 73 (4) 66-80 35 (11) 11-63 6 (4) 1-15 
Paper II       
PwPD 105 46/54 57/43 73 (6) 61-87 33 (12) 12-76 6 (5) 1-25 
Healthy controls  47  57/43 71 (6) 60-88   
PwPD mild 48 100/0 54/46 72 (6) 63-83 30 (10) 12-75 4 (4) 1-17 
PwPD moderate 57 0/100 60/40 73 (6) 61-87 35 (12) 16-76 7 (6) 1-25 
PwPD fallers 46 44/56 52/48 73 (5) 63-84 34 (13) 12-76 6 (6) 1-25 
PwPD  nonfallers 59 48/52 61/39 73 (6) 61-87 32 (11) 14-75 5 (4) 1-19 
Paper III       
PwPD training 47 43/57 60/40 73 (6) 61-87 36 (10) 17-62 6 (5) 1-25 
PwPD control 44 43/57 51/49 74 (5) 65-87 37 (11) 14-57 6 (5) 1-21 
Paper IV       
PwPD Training 45 42/58 60/40 73 (6) 61-87 32 (12) 12-75 6 (5) 1-25 
PwPD Control 42 43/57 50/50 74 (6) 65-87 33 (12) 16-76 5 (5) 1-21 
PwPD= People with Parkinson’s disease; n=number; UPDRS, motor=Unified Parkinson’s disease rating scale, part III; SD= Standard deviation; Mild= Hoehn and Yahr stage 2; moderate= Hoehn 
and Yahr, stage 3.  
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Table III. An overview of the measurement instrument used in this thesis 
Instruments Paper I Paper II Paper III Paper IV 
The Mini-BESTest        
UPDRS-motor          
MMSE         
The TUG      
The UPDRS-ADL       
GaitRITE       
Cognitive task       
Accelerometers      
FES-I      
The Mini-BESTest= a clinical multi-item tool stated to measure dynamic balance 
UPDRS, motor= the Unified Parkinson’s Disease Rating scale, part III, a test to assess severity of motor 
symptoms  
MMSE=the Mini-Mental State Examination score, a test to screen for cognitive impairments  
TUG= the Timed Up and Go test, a test to assess functional mobility  
UPDRS-ADL=  the Unified Parkinson’s Disease Rating scale, part II, a test to assess disease related 
Activities of Daily Living  
GaitRite®= an electronic walkway to assess gait during single- and dual-task conditions  
Cognitive task= reciting alternate letters of the Swedish alphabet, performed as a single and dual-task, 
respectively  
Accelerometers= Devices that can be used to measure an individual’s acceleration 
FES-I=Falls efficacy scale-international, a test to assess fear of falling 
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Table IV. Summary of the subcomponents and items of the Mini-BESTest.
a
 
     
Subcomponents Anticipatory Reactive postural control Sensory orientation Dynamic gait 
Items 1. Sit to stand 
 
4. Compensatory stepping correction- forward 7. Stance (feet together); 
eyes open, firm surface 
10. Change in gait speed 
 2. Rise to toes 
 
5. Compensatory stepping correction- backward  8. Stance (feet together); 
eyes closed, foam 
surface  
11. Walk with Head turns- 
horizontal  
 3. Stand on one leg, left 
and right
b 
 
6. Compensatory stepping correction- lateral,   
left and right
b 
9. Incline, eyes closed 12. Walk with pivot turns 
    13. Step over obstacles 
    14. Timed up & go with dual-task 
a 
Maximal score 28 points. 
b
 Only the score of the worst side was used to calculate the total score. 
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4.7.2 The Unified Parkinson’s disease rating scale  
The Unified Parkinson’s Disease Rating scale (UPDRS) was developed to enable 
comprehensive monitoring of PD related disabilities and symptoms.
150
 This scale entails four 
parts: part I concerns mentation, behaviour and mood; part II concerns activities of daily 
living); part III investigates motor symptoms; and part IV focuses on complications.  
Within this thesis the parts investigating disease related motor symptoms (III) and activities 
of daily living (II) are used.      
 
4.7.2.1 UPDRS, motor (part III) 
The UPDRS, motor, was used to assess the severity of motor symptoms commonly observed 
in PwPD. Such symptoms include: bradykinesia, rigidity, tremor, postural instability during 
transfers and gait. Moreover, the UPDRS, motor, also includes a retropulsion test,
151
 that is, a 
test that assesses how PwPD react to rapid perturbation in the backwards direction. Here the 
number of steps required to regain balance control is commonly used
150
 to distinguish 
between mild (H&Y≤ 2) and moderate to severe (H&Y ≥ 3) disease severity, where the use 
of more than two steps is interpreted as postural instability.
151
  The UPDRS, motor, contains 
27 items, each contributing to the total score that amounts to 108. A higher score is 
interpreted as more severe motor symptoms.
152
  The UPDRS, motor, have been found valid
150
 
and reproducible.
153
 In this thesis, the UPDRS, motor, is used as a descriptor of disease 
severity. 
 
4.7.2.2 Activities of daily living part (II) 
The UPDRS, activities of daily living (ADL), measures disease related ADL. This is assessed 
by means of a questionnaire, and can either be administered via an interview or as self-report 
questionnaire (in this study an interview was performed).
150
 Thirteen items are included in 
this questionnaire, including questions ranging from the self-perceived ability to eat and wash 
to the occurrence of falling and gait abilities. The score of each item is subsequently 
calculated to produce a total score that has a maximum of 52. A higher score is interpreted as 
more severe limitations of ADL. The UPDRS, ADL, has previously been found valid and 
reproducible.
154,155
 In this thesis, the UPDRS, ADL was used as an outcome measure in 
papers II and III. 
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4.7.3 The Mini-Mental State Examination score 
The Mini-Mental State Examination score (MMSE) is test of cognitive function, stated to 
cover areas such as orientation, registration, attention and calculation, recall and language.
156
 
This test, entailing 11 items, is evaluated based on a total score. The maximal score is 30 of 
which a score below 24 is considered an indication of cognitive impairment.
156
 The 
Movement Disorder Society Task force has recommended MMSE to be used in PwPD.
157
 In 
this study, a score of at least 24 was a requirement to be included in the randomised 
controlled trial.    
 
4.7.4 The timed up and go test 
The timed up and go test (TUG) is a clinical test evaluating the construct of physical 
mobility,
158
  and has been found reproducible and valid in PwPD.
159
 The test itself measures 
the time it takes for a subject to perform the following sequence: stand up from a standard 
arm chair, walk a distance of 3 meters, turn 180 degrees, walk back to the chair, and sit down 
again. In this thesis, the TUG test was performed during the performance of item 14 of the 
Mini-BESTest. The TUG is an outcome measure in paper II. 
 
4.7.5 The GAITRite® electronic walkway system 
For the assessment of gait during ST and DT-conditions the GAITRite® system was used 
(CIR Systems, Inc., Haverton, PA, USA). This is a nine metre (active zone: 8.3 meters) 
electronic walkway that is connected to a computer. The walkway has embedded pressure 
sensors that allow for the detailed investigation of specific gait parameters.  The GAITRite® 
system has been found to be valid and reproducible when measuring gait performance in 
PwPD.
160,161
   
For both ST and DT-conditions, (which was preceded by a practice session aimed at 
minimising the risk of learning bias) walking was performed by means of ordinary over-
ground walking. Acceleration and deceleration distances of three 3 meters was given on each 
side of the walkway to ensure steady state walking when gait was measured .
162
  When 
assessing gait, the participants were instructed to repeatedly walk at self-selected (normal) 
speed. This continued until six valid trials of each condition had been captured. However, the 
participants were not informed of this on beforehand in order to avoid bias. Moreover, in 
order to minimise the risk of fatigue affecting the results, all participants were required to sit 
down and rest in the midst of the gait assessments. During the DT-condition, the participants 
were instructed to pay equal attention to the walking and the added task at all times. 
Within this thesis, both the ST and DT-gait performance, respectively, were used as outcome 
measures in paper III. The relation between ST and DT-gait (i.e. automaticity) was used as 
outcome measure in paper IV. 
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4.7.6 The added task during the single and dual-task conditions 
The added task that was chosen for this intervention was a cognitive task which was 
influenced by the walking while talking paradigm.
163,164
 This task, which has been found to 
predict falls in older people,
165
 entailed the reciting of alternate letters of the Swedish 
alphabet at self-selected speed, and was performed under both ST (while seated) and DT- 
conditions (during gait) following a randomised sequence.   
When the added task was performed during the DT-condition, the participants were 
instructed to start reciting as soon as they started to walk and to continue until they had 
stopped. Importantly, only the letters recited while the participants walked upon the walkway 
were recorded.  
The participants performed the added task under the ST-condition until three valid trials had 
been recorded. Each trial lasted 15 seconds, starting when the participants initiated reciting. 
However, only the letters recited between the fifth and fifteenth seconds were recorded, in 
order to resemble the DT- condition. In order to minimise practice bias, the participants 
received different starting letters following a standardised scheme shortly before each trial 
started.
164
 Moreover, the performance of the added task, both under ST and DT-conditions, 
was included in the above mentioned practice session.  
Within this thesis, the performance of the added task under ST and DT -conditions, 
respectively, was used as outcome measures in paper III. Similar to gait, the relation between 
the ST and the DT performance (i.e. automaticity) was used as outcome measure in paper IV. 
 
4.7.7 Falls Efficacy Scale International 
The Falls efficacy scale international (FES-I)
166
 is a self-report questionnaire assessing fall-
related concerns with regard to specific daily activities. The FES-I entails 16 items, each of 
which are scored separately on a scale ranging from one to four. The score of each item sum 
to a maximum of 64, where a higher number is interpreted as a higher fall-related concerns. 
The FES-I has shown satisfactory psychometric properties when used in PwPD.
167
  
In this thesis, the FES-I was an outcome measure in paper III. 
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4.7.8 Accelerometers 
Accelerometers refer to devices that can be used to measure an individual’s acceleration, for 
example while walking. In this study accelerometers (Actigraph GT3X+, Pensacola, FL, 
USA) were used to assess physical activity levels before and after the training intervention. 
Following the assessments in the movement laboratory, included participants were asked to 
wear accelerometers for seven consecutive days. The device was attached to an elastic band 
that was worn around the waist, with the accelerometers positioned at the hip. Data were 
sampled at 30Hz and subsequently processed by means of the ActiLife 6 software 
(ActiGraph, Pensacola, FL, USA). The Actigraph GT3X+ has shown appropriate 
psychometric properties with regard to the assessments of energy expenditure in old 
people.
168
    
 
4.8 PROCEDURES 
 
4.8.1 Paper I 
To investigate inter-rater reproducibility two physiotherapists with different expertise and 
experience of the Mini-BESTest administered and rated the test performance of the included 
PwPD on the same day at a university hospital. The more-experienced rater (rater A) had 
administered and rated the Mini-BESTest more than 100 times, whereas the less-
experienced rater (rater B) had administered the test approximately ten times before this 
study started. To synchronise their assessment of the Mini-BESTest, the two raters met 
prior to the study on two occasions to discuss the principles of the test, and to practice its 
administration and rating. However, during and after the test sessions the raters were 
blinded to each other’s ratings. Participants were briefly interviewed, using a standardised 
protocol, regarding current health status including years since diagnosis. Disease severity 
was measured with the UPDRS, motor
154
 and cognitive function was assessed with the 
MMSE. Subsequently, the participants performed the Mini-BESTest with each of the two 
test administrators, who were situated in separate rooms. Randomisation decided which 
administrator to start with. The test procedure took approximately one hour to complete.  
For test-retest reproducibility, the more experienced rater (rater A) reassessed the 
participants seven days later. At the second test session, rater A performed a brief 
interview, including questions regarding pain, medication, activity, falls, and other possible 
incidents that might have influenced their balance performance since the previous session. 
Following this, the participants performed the Mini-BESTest at the same location and time 
of the day as they had performed the test the previous week. 
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4.8.2 Paper II 
Included participants underwent an interview regarding current health status and were 
screened with the UPDRS, motor. Subsequently, the participants, in a randomised order, 
performed the Mini-BESTest, the TUG and the UPDRS, ADL. All participants completed 
every item of each test.  
During each test session, the same assessor instructed and rated all tests independently. For 
practical reasons, four different physiotherapists served as test assessors. In order to 
standardise their instructions and ratings, all assessors took part in a training session prior to 
the commencement of the study. 
 
4.8.3 Papers III &IV 
The HiBalance intervention was performed at two geographical cohorts (north and south) in 
order to reduce travel times for the included participants. Randomisation, performed in blocks 
of four by, means of opaque envelopes (sealed and numbered) was separate for the respective 
geographical cohort. Therefore all participants were required to choose geographical cohort 
to be assigned to prior to taking part in the assessments, should they be included in the study. 
Following the baseline assessments, the included participants were randomised to the training 
group or control group. 
Although the testers were blinded to group allocation at the baseline assessments, this was not 
possible at follow-up since some testers also served as trainers. In an attempt to decrease bias, 
testers that had served at trainers in one geographical cohort never assessed participants from 
that cohort during the follow-up assessments.   
Participants that had been randomised to the training group participated in 10-weeks of highly 
challenging gait and balance training. The participants that had been randomised to the 
control group were encouraged to continue with their usual habits. They were neither 
discouraged nor encouraged to participate in organised training during the time of the study.   
  
4.8.3.1  Training programme 
The HiBalance training programme, a highly challenging gait and balance training that 
specifically targets well established impairments among PwPD, was performed in groups of 
4-7 participants for 10 weeks (3 times á 60min/week). Each training session was supervised 
by 2 physiotherapists.  
The core of the training programme consisted of 4 components specific to gait and balance 
impairments in PwPD: (1) Sensory integration (walking tasks on varying surfaces with or 
without visual constraints); (2) Anticipatory postural adjustments (voluntary arm/leg/trunk 
movements, postural transitions, and multidirectional stepping, emphasizing movement 
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velocity and amplitude); (3) Motor agility (inter-limb coordination under varying gait 
conditions and quick shifts of movement characteristic during predictable and unpredictable 
conditions); and (4) Stability limits (controlled leaning tasks performed while standing with 
varying bases of support, stimulating weight shifts in multiple directions). 
The 10-week period was divided into 3 blocks (A; B; and C). In block A (weeks 1–2); 
participants were introduced to the ST-exercises of each balance component separately, in 
order to emphasise the quality of movement and the objectives of the exercises. In block B 
(weeks 3–6); DT-exercises were introduced and the difficulty level for each balance 
component was increased. In block C (weeks 7–10); the difficulty level and the variation was 
increased further by using exercises that combined the different balance components.  
DT-exercises were gradually integrated into the program by adding concurrent cognitive 
tasks and/or motor tasks to the gait and balance exercises. The added tasks were mainly 
focusing on encouraging the continuous processing while walking under different 
circumstances. Examples of this included the silent counting of every step, or collaboration 
tasks (e.g. walking pairwise while exchanging words that starts with the same letter as the 
previous word ended with, or throwing balls to each other). The latter examples required the 
participants to continuously pay attention to their companion’s performance and try to 
produce an adequate response, whether cognitive or manual. However, the DT exercises used 
during training were never the same as used at pre- and post-assessments (i.e. any task 
resembling alphabet reciting was prohibited). 
Apart from the specific DT-exercises, the programme generally incorporated attentional 
demanding situations even during the ST-training (e.g. switching between tasks during gait in 
varied obstacles courses; spatial awareness in relation to obstacles; and collaborative tasks 
between participants).  
Highly challenging training was defined as exercises where the participants intermittently 
needed to use reactive postural adjustments to maintain balance control during ST-exercises. 
Similarly, the difficulty level for DT-exercises was to achieve consistent interference of the 
participants’ motor performance when compared to ST-performance (e.g. interfering with 
speed, movements’ fluency or step to step fluctuations). 
Since this training concept relied upon the continuous progression and adaptation of exercises 
with regards to the participants’ abilities, it was dependent of educated and skilled trainers. 
Therefore, all the trainers involved in this study were physiotherapists (n = 10) that were 
educated in detail about the underlying theories that the programme was based upon, as well 
as its practical applications. In addition, the trainers documented the contents of each training 
session and were supported in the practical aspects of the training upon request. 
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4.9 DATA ANALYSIS 
 
Table V summarises the statistical methods that have been used in this thesis. 
 
 
 
Table V. A summary of the statistical methods used in the respective papers of this thesis.  
 Paper I Paper II Paper III Paper IV 
Descriptive     
Mean         
Median        
Standard deviation          
Inter quartile range       
Range        
95% Confidence Interval         
     
Statistical methods     
Intra class correlations 2.1      
Cronbach’s alpha?      
Smallest error of measurement
 agreement 
     
Smallest real difference
ind 
     
Smallest real difference
group
      
Independent t-test         
Mann-Whitney U test        
Hedges g effect size      
Receiver operating curves       
Spearman’s rho      
Spearman’s correction for attenuation      
Williams T2 formula      
Repeated measures anova      
Tukey’s HSD      
Cohens d effect size      
Wilcoxon signed rank test       
Mann-Whitney U effect size       
 
 
4.9.1 Paper I 
Statistical analyses were performed with SPSS (version22, SPSS Inc., Chicago, IL). 
Reliability was investigated by means of ICC2.1 where one-way repeated measures 
analysis of variance (ANOVA) were used to calculate agreement between the raters (inter-
rater reproducibility) and test sessions (test-retest reproducibility), regarding the total score 
of the Mini-BESTest as well as its subcomponents. To categorise the level of ICC 
agreement, we used Altman’s classification: < 0.20 = poor; 0.21–0.40 = fair, 0.41–0.60 = 
moderate, 0.61–0.80 = good, 0.81–1.0 = very good.169  
For parameters of agreement, first SEMagreement was calculated as follows: SEM= 
√within subject error variance.140 Following this, the SRDind
140
 was calculated with a 95% 
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confidence interval, resulting in the following formula: SRD = 1.96 × √2 × SEM.139 To 
evaluate the proportion of the measurement error, the SRD% was clculated by dividing the 
SRD with the maximal total score of the Mini-BESTest (28 points). Similarly, the SRDind 
of each subcomponent was divided with its maximal total score (6 or 10 points). 
Supplementary analyses specific to this thesis was later performed by calculating the 
agreement on a group level, i.e. SRDgroup ,
140
 to relate the absolute measurement error to the 
group of participants in paper III. The calculation used was: the SRDind /√91.
140
 Moreover, 
in order to evaluate the magnitude of agreement, the SRD% on group level, i.e. SRDgroup%, 
was divided with the maximal score, and the maximal score of each subcomponent, of the 
Mini-BESTest. 
 
4.9.2 Paper II  
 
Statistical analyses were conducted with STATISTICA software (Statsoft, version 12, 
Tulsa, OK, USA) and SPSS (SPSS Inc, version 17, Chicago,Illinois).  
Independent t-tests were used to investigate the hypotheses that that Mini-BESTest scores 
(total score) would be significantly lower among: (1) PwPD compared to healthy controls; (2) 
PwPD with moderate disease severity compared to those with mild severity; and (3) recurrent 
fallers compared to non-recurrent fallers with mild to moderate PD.  
Due to the lack of normal distributions, Mann-Whitney U Tests were used to investigate 
between-group differences regarding the subcomponents of the Mini-BESTest, where the 
hypotheses were identical to those regarding the total score. Level of significance was set to 
p=0.05. 
Effect sizes (ES) were calculated in order to estimate the magnitude of between-group 
differences. Since there was a difference in group sizes, the Hedges g formula was used: M1-
M2/SD*pooled.
170
 The ES were categorized as: small (d=0.2); medium (d=0.5); and large 
(d≥0.8).171 
The Spearman’s rho test was used (due to a lack of normal distribution with regard to the 
respective scores of the TUG and the UPDRS, ADL) to determine how scores produced by 
the Mini-BESTest correlated with scores of similar (convergent validity) and different 
(divergent validity) constructs. The strength of the correlations was classified as follows: 
<0.40=poor; 0.41-0.60= moderate; 0.61-0.80= good; and 0.81-1.00= very good.
172
  
The Williams T2 formula was used to investigate the statistical difference between the 
strength of the correlations for convergent and divergent validity.
173
 
Moreover, the correlation between two measures is inevitably attenuated with regards to the 
reliability of each measure. This means that a measure can never produce a higher association 
with another measure compared to itself when assessed at two different occasions. Hence, to 
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obtain the true correlation, Spearman suggested a calculation based on the correlation 
between the two measures and the correlation obtained from test-retest measurements of each 
measure.
174,175
 Since we had test-retest data for this population, we were able to estimate the 
true correlation between these measures. 
Supplementary analyses were performed to investigate the potential occurrence of floor 
and/or ceiling effects of the Mini-BESTest as well as the subcomponents. Floor and ceiling 
effects, respectively, were determined to occur if at least 15 percent of the participants 
achieved the lowest or highest score available on the Mini-BESTest or the subcomponents.    
 
4.9.3 Paper III  
Statistical analysis was conducted using STATISTICA software (Statsoft, version 12, 
Tulsa, OK, USA). The Student t test, Mann-Whitney test, and the χ2 test were used to 
assess the homogeneity of the groups at baseline. To test for equality of variance and data 
normality, Levene’s test was used, combined with a visual inspection of the normally 
distributed and residual curve. On fulfilment of these criteria, a 2-factor repeated-measures 
analysis of variance was performed to test for interaction effects between groups (training 
group vs control group) and with time (pre-test and post-test). In the case of significant 
interaction effects, Tukey’s post hoc analyses were performed to assess differences between 
pre- and posttest. For outcomes with skewed data distributions, log-transformations were 
conducted, and if normally distributed afterward, an analysis of variance was used. For 
outcomes without normal distribution even after log-transformation (ie, performance of the 
cognitive DT), the Mann-Whitney U test was used to determine between-group differences 
(ie, calculated as the difference between pre- and posttest performances) and if significant, 
the Wilcoxon signed rank test was used to determine within-group differences between pre- 
and posttest in each group separately. Effect size between the 2 independent groups was 
computed using Cohen’s d calculation. We used both an intention-to-treat (last value 
carried forward data imputation) and a per-protocol approach. However, since these 
analyses revealed similar results, and given the small dropout rate, only the results for the 
per-protocol analysis are reported. Significance level was set at P ≤ 0.05. 
Supplementary analyses were performed to investigate between-group differences with 
regards to the subcomponents of the Mini-BESTest. To test for equality of variance and data 
normality, the Kolmogorov-Smirnoff test was used, combined with a visual inspection of the 
normally distributed and residual curve. Due to lack of normal distributions, the Mann-
Whitney U test was performed to assess between group differences at baseline. If no baseline 
differences occurred, the Mann-Whitney U test was also used to compare the groups at the 
follow up assessments. To obtain information regarding the magnitude of between-group 
differences at follow-up, non-parametric effect sizes were calculated based on the z-value 
obtained from the Mann-Whitney U tests, by using the following formula: r=z/√n. The 
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categorisation of the effect sizes were as follows: small effect=0.1;  medium effect=0.3; and 
large effect=0.5.
176
  
To investigate if effects of training were consistent with regards to the time and geographical 
cohorts, within-training group analyses were performed with regards to the difference 
between the baseline and follow-up assessments. 
4.9.4 Paper IV  
The gait parameters related to the gait model were calculated in accordance with 
recommendations,
37,43
 that is: the mean and the variance of right and left steps were 
calculated separately. The mean gait parameters (step velocity, step length, step time, swing 
time, stance time and step width) were calculated as the mean of right and left step means. 
Asymmetry parameters were calculated as the absolute difference between the means of right 
and left steps. Variability parameters were calculated as the square root of the mean variance 
of the right and the left steps. This is a method that has been proposed to “clean” the 
variability parameters from variability that may derive from asymmetric gait.
161
 
DTI was calculated as the absolute difference between the DT and ST-conditions (DT-ST). 
This was performed for all gait parameters; as well as for two cognitive parameters that were 
used to complement to each other: cognitive performance and cognitive performance 
variability. Cognitive performance entails the mean performance of the cognitive task and 
was calculated as the total mean of: the number of errors /the total number of letters recited 
per trial. Cognitive performance variability, which can be considered a measure of cognitive 
processing robustness,
177
 refers to the intra-individual variability of the cognitive 
performance and was calculated as the standard deviation of the cognitive performance across 
trials.
178
  
Statistical analysis was conducted using STATISTICA software (Statsoft, version 12, Tulsa, 
OK). To test for equality of variance and data normality, the Kolmogorov-Smirnoff test was 
used, combined with a visual inspection of the normally distributed and residual curve. 
Due to lack of normal distributions, non-parametric statistics were applied. The Mann-
Whitney U test was applied to analyse between-group differences (calculated as the 
difference between the baseline and the follow-up assessments). If a significant between-
group difference was found, the Wilcoxon Signed Rank Test was used to analyse within-
group differences. Effect sizes were calculated to obtain information regarding the magnitude 
of between-group differences. Since the data was not normally distributed, our calculations 
were based on the z values obtained from the Mann-Whitney U tests by using the following 
formula: r=z/√n. The categorisation of the effect sizes were as follows: small effect=0.1;  
medium effect=0.3; and large effect=0.5.
176
 
In addition, specific to this thesis, the results of all gait parameters that are presented in forms 
of the relative measure DTI, are also presented as absolute ST and DT measures in order to 
increase the interpretability. 
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5 RESULTS 
 
5.1 THE REPRODUCIBILITY OF THE MINI-BESTEST 
For the reproducibility of the Mini-BESTest, both inter-rater and test-retest reliability was 
found to be good (ICC= 0.72; and 0.80, respectively), whereas the investigation of the 
proportional measurement error was considered high (SRD%=14.6; and 12.1, respectively).   
Regarding the Mini-BESTests subcomponents, the inter-rater reliability was good for 
anticipatory postural adjustments (ICC=0.65), whereas it was moderate for postural 
responses, sensory orientation and dynamic gait (ICC ≤ 0.54). For inter-rater agreement, 
postural responses accounted for the largest proportional measurement error (SRD%=38.3) 
whereas it was lowest for sensory integration (SRD%=16.7). 
 For the test-retest reliability of the subcomponents, reproducibility was good for anticipatory 
postural adjustments, postural responses and dynamic gait (ICC ≥ 0.70) whereas it was 
moderate for sensory orientation (ICC=0.54). Conversely, for test-retest agreement, the 
proportional measurement error was lowest for sensory orientation and highest for postural 
responses (SRD%= 13.3; and 26.7; respectively). 
Table VI illustrates the agreement of the overall findings of the Mini-BESTest’s 
reproducibility in PwPD with mild to moderate disease severity (including the SRDgroup 
findings, which are related to the sample size of the randomised controlled trial). 
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Table VI. Inter -rater and test-retest reproducibility for the Mini-BESTest and its subcomponents. 
 Mean SD Range Mean SD Range ICC2.1 Cronbach’s alpha SEM SRDind SRDind% SRDgroup SRDgroup% 
Inter-rater reproducibility Rater A Rater B         
Mini-BESTest, total score 20.2 2.6 15-25 21.3 2.7 15-26 0.72 0.87 1.5 4.1 14.6
1 
0.4 1.5
1 
Anticipatory postural adjustments 3.6 1.2 1-6 4.1 1.0 2-6 0.65 0.83 0.7 1.9 31.7
2 
0.2 3.3
2 
Postural responses 4.2 1.0 3-6 3.7 1.1 1-6 0.43 0.63 0.8 2.3 38.3
2 
0.2 4.0
2
 
Sensory orientation 5.7 0.6 4-6 5.9 0.5 4-6 0.54 0.70 0.4 1.0 16.7
2 
0.1 1.8
2 
Dynamic gait 6.7 1.4 5-10 7.7 1.1 5-9 0.48 0.75 1.1 2.9 29.0
2 
0.3 3.0
2 
               
Test-retest reproducibility Session 1 Session 2         
Mini-BESTest, total score 20.2 2.6 15-25 20.5 2.9 14-26 0.80 0.88 1.2 3.4 12.1
1 
0.4 1.3
1 
Anticipatory postural adjustments 3.6 1.2 1-6 3.7 1.1 2-6 0.79 0.88 0.5 1.4 23.3
2 
0.2 2.5
2 
Postural responses 4.2 1.0 3-6 4.4 1.1 3-6 0.70 0.83 0.6 1.6 26.7
2 
0.2 2.8
2 
Sensory orientation 5.7 0.6 4-6 5.9 0.4 5-6 0.54 0.77 0.3 0.8 13.3
2 
0.1 1.4
2 
Dynamic gait 6.7 1.4 5-10 6.5 1.7 4-10 0.78 0.87 0.7 2.0 20.0
2 
0.2 2.1
2 
               
SD= Standard Deviation; ICC = Intra Class Correlation; SEM = Standard Error of Measurement (√within subjects error variance); SRD ind = Smallest Real Difference on individual level 
(1.96 x √2 x SEM); SRDind%= 
1
SRDind/maximal Mini-BESTest score x100; 
2
SRDind/ maximal subcomponent score x 100; SRDgroup= SRDind/√91; SRDgroup%=
1
SRDgroup/maximal Mini-
BESTest score x100; 
2
SRDgroup/ maximal subcomponent score x 100. 
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5.2 THE CONSTRUCT VALIDITY OF THE MINI-BESTEST 
 
The results showed that the Mini-BESTest scores were significantly worse among:  PwPD 
compared to age matched controls (p=0.001; ES=1.17); and PwPD with moderate disease 
severity compared to those with mild severity (p=0.001; ES=1.09). However, there were no 
differences between PwPD with a reported history of recurrent falls as compared to non-
recurrent fallers (p=0.096; ES=0.32).  
In addition, the Mini-BESTest showed a moderate relationship with the TUG (rho=-0.586), 
and a poor relationship with the UPDRS-ADL (rho=-0.260). 
 
5.2.1.1 Floor/ceiling effects of the Mini-BESTest and its subcomponents 
No floor effects were found for the total score Mini-BESTest or any of the subcomponents. 
Nor were any ceiling effect present for the Mini-BESTest’s total score (0%); APA’s (6%); 
Postural Responses (7%); or Dynamic Gait (2%). However for Sensory Orientation, 48% of 
the PwPD obtained the maximal score possible. The distribution of scores for the Mini-
BESTest and the respective subcomponents is illustrated in Figure 5.   
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Figure 5. Illustrating the distribution of scores regarding (A) the Mini-BESTest (total score); 
(B) the respective subcomponents of the Mini-BESTest. 
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5.3 OVERALL EFFECTS OF GAIT AND BALANCE TRAINING 
The results showed that the training group, in comparison with the control group, 
significantly improved the performance of the Mini-BESTest (p=0.001). The training group 
also improved velocity and step length during ST-gait (p=0.018; and p= 0.015, respectively) 
whereas cadence was unaffected (0.108). Although none of the aforementioned parameters 
were affected during the DT-condition (p≥0.469), the training group improved the 
performance of the cognitive task when performed as a DT but not when performed as an ST 
(p=0.006; and p=0.634, respectively). Moreover there were no between-group effects on fall-
related concerns (FES-I; p=0.772). However significant between-group differences 
(p=≤0.033) were found for the UPDRS, ADL and the accelerometer measurements (i.e. total 
number of steps per day).   
 
5.3.1.1 Within training-group effects with regards to training period 
There were no differences between the training groups with regards to the three time periods 
that training had been undertaken, the median Mini-BESTest improvement for period 1, 2 
and 3, respectively, was: 3, 4, and 2 points (p=0.189).  
 
5.3.1.2 Within training-group effects with regards to geographical cohort 
There were no between-group differences when comparing the participants that had 
participated in training at the two different geographical cohorts (p=0.850). The mean Mini-
BESTest improvement was 3.1 points for the northern cohort and 3.0 points for the southern 
cohort.   
 
5.3.1.3 Training effects on the subcomponents of the Mini-BESTest 
The results showed that the training group, compared to the controls, improved the 
performance of APA and dynamic gait moderately (ES= -0.33) whereas the improvement of 
postural responses was small (ES=0.24). The performance of sensory orientation on the other 
hand was unaffected (p=0.159). These findings are illustrated in Table VII and Figure 6.  
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Table VII. Treatment effects of the Mini-BESTest’s subcomponents between the training group and control group. 
 Training group n=47  Control group n=44 
 Median (IQR)  Median (IQR)  
 Baseline Follow-up Difference  Baseline Follow-up Difference p-value 
Anticipatory postural adjustments 3.0 (2.0) 4.0 (2.0) 1.0 (1.0)  3.0 (2.0) 3.5 (1.0) 0.0 (0.5) 0.001 
Postural responses 3.0 (1.0) 4.0 (1.0) 1.0 (2.0)  4.0 (1.0) 4.0 (1.5) 0.0 (1.0) 0.023 
Sensory orientation 6.0 (1.0) 6.0 (1.0) 0.0 (1.0)  5.0 (1.0) 6.0 (1.0) 0.0 (1.0) 0.159 
Dynamic gait 7.0 (1.0) 8.0 (2.0) 1.0 (2.0)  7.0 (1.5) 7.0 (2.0) 0.0 (1.0) 0.001 
IQR=Inter quartile range; Difference= Median difference between the baseline and follow-up assessments 
 
 
 
 
 
Figure 6. Illustration of the magnitude of differences between the training and control group 
with regards to the Mini-BESTest’s total score and the subcomponents. An effect size of 0.1 
equals a small effect, and an effect size of 0.3 equals a medium effect.  
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5.4 EFFECTS OF DUAL-TASK GAIT TRAINING ON AUTOMATICITY AND 
ATTENTION ALLOCATION 
As shown in Table VIII there were no DTI differences between the groups with regards to 
any gait parameter of any gait domain (P ≥ 0.084). However, the between-group differences 
of cognitive performance and cognitive variability (p=0.018; and p=0.038, respectively) 
revealed that the training group had improved both parameters significantly (p=0.038; and 
p=0.032, respectively). Figure 7 illustrates the effect sizes between the groups and their 
direction.  
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Figure 7. An illustration of the magnitude of dual-task interference differences (effect sizes) 
between the training group and the control group, measured as the difference between the 
baseline and follow-up assessments. The dotted line represents an effect size of 0.1 (small 
effect). The bars on the left side indicate that the control group has improved this parameter, 
whereas the bars on the right side indicate that the training group has improved this 
parameter.  
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Table VIII. Treatment effects with regards to dual-task interference for the training group and control group at baseline and 10-week follow-up. 
 Training group (n=45) Control group (n=42)   
Pace Domain 
Median (IQR) Median (IQR) 
Effect 
size
a
 
P-value 
Between 
group
b Baseline Follow-up Difference Baseline Follow-up Difference 
DTI Step Velocity (m/s) -0.173 (0.221) -0.180 (0.250) -0.001 (0.218) -0.184 (0.310) -0.167 (0.217) -0.028 (0.218) 0.11 0.290 
DTI Step Length (m) -0.047 (0.070) -0.035 (0.080) -0.006 (0.056) -0.044 (0.076) -0.036 (0.052) -0.018 (0.058) 0.11 0.298 
DTI Swing Time Variability (ms) 7.8 (11.7) 6.7(11.4) -0.9 (10.8) 10.0 (29.1) 8.9 (19.0) 2.9 (16.1) -0.19 0.084 
Rhythm Domain         
DTI Step Time (ms) 36.1 (65.5) 38.2 (65.7) 6.5 (49.4) 55.1 (114.1) 47.8 (108.8) 9.3 (64.2) -0.05 0.662 
DTI Swing Time (ms) 13.2 (36.2) 16.9 (43.9) 4.5 (40.8) 12.8 (59.1) 17.7 (61.6) 0.9 (39.2) -0.02 0.842 
DTI Stance Time (ms) 72.9 (109.6) 64.9 (95.8) 3.2 (69.9) 96.0 (171.9) 75.4 (168.0) 9.9 (117.3) -0.04 0.731 
Variability Domain         
DTI Step Velocity Variability(m/s) 0.026 (0.029) 0.018 (0.030) 0.002 (0.040) 0.017 (0.028) 0.022 (0.031) 0.002 (0.027) 0.03 0.802 
DTI Step Length Variability (m) 0.008 (0.016) 0.007 (0.011) -0.000 (0.016) 0.008 (0.011) 0.008 (0.014) 0.000 (0.018) -0.12 0.246 
DTI Step Time Variability (ms) 13.2 (19.3) 8.7 (16.7) 0.9 (18.9) 12.8 (33.1) 12.9 (28.3) 3.6 (22.8) -0.10 0.352 
DTI Stance Time Variability (ms) 18.2 (29.2) 11.4 (21.9) 3.2 (69.9) 21.1 (43.9) 16.7 (43.0) 9.9 (117.3) -0.04 0.731 
Asymmetry Domain         
DTI Swing Time Asymmetry (ms) 1.4 (9.3 ) 1.9 (12.5) -2.5 (11.3) 3.6 (16.8) 3.5 (17.5) 0.3 (12.3) -0.18 0.093 
DTI Step Time Asymmetry (ms) 3.5 (16.5) 3.5 (13.8) 3.4 (16.6) 5.4 (26.4) 4.8 (21.4) 1.2 (19.9) -0.08 0.462 
DTI Stance Time Asymmetry (ms) 3.2 (12.7) 2.6 (11.4) -0.5 (11.8) 8.1 (19.5) 3.0 (18.0) 3.6 (19.6) -0.17 0.104 
Postural Control Domain         
DTI Step Length Asymmetry (m) 0.002 (0.025) 0.001 (0.024) 0.007 (0.027) 0.000 (0.027) -0.001 (0.029) 0.003 (0.021) 0.09 0.422 
DTI Step Width (m) 0.009 (0.012) 0.009 (0.015) -0.001 (0.013) 0.012 (0.015) 0.009 (0.010) 0.002 (0.014) -0.16 0.138 
DTI Step Width Variability (m) 0.001 (0.006) 0.002 (0.007) -0.001 (0.008) 0.000 (0.005) 0.001 (0.006) -0.000 (0.005) -0.08 0.473 
Cognitive Task         
DTI Cognitive Performance 8.8 (18.5) 4.4 (16.2) 5.1 (29.0) 5.9 (28.2) 7.5 (25.3) -3.6 (25.6) 0.26 0.018 
DTI Cognitive Performance 
Variability 
1.9 (9.2) -1.6 (10.7) 3.3 (11.0) 1.3 (12.6) 1.4 (8.5) -0.6 (12.9) 0.22 0.038 
Abbreviations: IQR= Inter quartile range; DTI = Dual-Task Interference; m/s=meters per second; m=meters; ms=milliseconds; 
Cognitive Performance= the number of errors /the total number of letters recited per trial; Cognitive Performance Variability= the Intra-individual standard 
deviation of the cognitive performance across trials. 
a 
Cohens r, non-parametric effect-size, computed using the following formula: r= z/√number of observations. bMann-Whitney U test to determine between-group 
differences (i.e., computed as the difference between follow-up and baseline performance). Bold = statistical significance (p < 0.05). 
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5.4.1.1 Single-task gait 
The analyses of the difference between the baseline and follow up assessments showed that in 
comparison to the control group, the training group improved parameters belonging to the 
pace domain (step velocity and step length) and the rhythm  domain (step time and stance 
time).  See Table IX. 
 
5.4.1.2 Dual-task gait  
The analyses of the difference between the baseline and follow up assessments showed that 
the control group significantly increased their step width in comparison with the training 
group (p=0.046). See Table X. 
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Table IX. Treatment effects with regards to single-task gait for the training group and control group at baseline and 10-week follow-up. 
 Training group (n=45) Control group (n=42)   
Pace Domain 
Median (IQR) Median (IQR) 
Effect 
size
a
 
P-value 
Between 
group
b Baseline Follow-up Difference Baseline Follow-up Difference 
Step Velocity (m/s) 1.21 (0.279) 1.28 (0.250) -0.109 (0.253) 1.18 (0.282) 1.18 (0.271) -0.007 (0.161) 0.26 0.016 
Step Length (m) 0.636 (0.143) 0.655 (0.094) -0.027 (0.054) 0.623 (0.094) 0.639 (0.101) -0.002 (0.061) 0.30 0.006 
Swing Time Variability (ms) 14.2 (5.4) 13.5 (4.5) 1.5 (4.8) 16.0 (5.8) 15.0 (8.9) 1.1 (6.2) -0.12 0.253 
Rhythm Domain         
Step Time (ms) 534.3 (54.4) 521.4 (62.0) 13.0 (36.4) 532.6 (4.6) 532.7 (38.4) -0.8 (34.5) -0.23 0.035 
Swing Time (ms) 382.6 (39.0) 381.5 (45.5) -2.1 (27.0) 384.5 (46.4) 380.8 (34.1) -0.2 (16.9) -0.02 0.836 
Stance Time (ms) 684.5 (68.4) 670.4 (77.8) 25.0 (62.4) 675.5 (75.0) 683.2 (65.0) -1.2 (47.4) -0.27 0.013 
Variability Domain         
Step Velocity Variability (m/s) 0.048 (0.015) 0.051 (0.014) -0.002 (0.022) 0.055 (0.016) 0.050 (0.018) 0.003 (0.023) 0.19 0.082 
Step Length Variability (m) 0.024 (0.008) 0.023 (0.007) 0.001 (0.007) 0.024 (0.010) 0.025 (0.009) 0.000 (0.009) -0.13 0.237 
Step Time Variability (ms) 15.3 (7.4) 14.5 (5.2) 1.3 (5.8) 17.8 (6.2) 16.6 (8.8) 0.2 (3.7) -0.09 0.395 
Stance Time Variability (ms) 17.7 (8.7) 16.8 (4.6) 1.4 (6.4) 20.0 (8.7) 19.0 (8.5) 0.6 (7.5) -0.05 0.645 
Asymmetry Domain         
Swing Time Asymmetry (ms) 8.8 (12.9) 7.2 (11.0) 0.6 (9.1) 9.7 (12.7) 8.7 (13.3) 1.3 (12.0) 0.01 0.963 
Step Time Asymmetry (ms) 14.0 (16.7) 10.3 (14.1) 3.6 (11.0) 13.5 (18.0) 12.9 (19.3) 0.8 (15.7) -0.09 0.410 
Stance Time Asymmetry (ms) 10.2 (12.0) 11.4 (13.2) 0.9 (9.6) 10.7 (11.6) 9.0 (13.4) 2.0 (11.5) 0.06 0.609 
Postural Control Domain         
Step Length Asymmetry (m) 0.027 (0.027) 0.028 (0.035) -0.001 (0.019) 0.027 (0.023) 0.030 (0.027) -0.001 (0.020) 0.04 0.707 
Step Width (m) 0.090 (0.031) 0.088 (0.036) -0.001 (0.011) 0.076 (0.036) 0.076 (0.039) 0.001 (0.014) 0.06 0.609 
Step Width Variability (m) 0.017 (0.009) 0.016 (0.007) -0.001 (0.006) 0.018 (0.006) 0.018 (0.007) -0.001 (0.006) -0.10 0.368 
Abbreviations: IQR= Inter quartile range; m/s=meters per second; m=meters; ms=milliseconds; 
a 
Cohens r, non-parametric effect-size, computed using the following formula: r= 
z/√number of observations. bMann-Whitney U test to determine between-group differences (i.e., computed as the difference between follow-up and baseline performance). Bold = 
statistical significance (p < 0.05). 
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Table X. Treatment effects with regards to dual-task gait for the training group and control group at baseline and 10-week follow-up. 
 Training group (n=45) Control group (n=42)   
Pace Domain 
Median (IQR) Median (IQR) 
Effect 
size
a
 
P-value 
Between 
group
b Baseline Follow-up Difference Baseline Follow-up Difference 
Step Velocity (m/s) 1.03 (0.289) 1.08 (0.272) -0.061 (0.168) 0.93 (0.411) 1.03 (0.378) -0.061 (0.290) 0.09 0.389 
Step Length (m) 0.590 (0.133) 0.602 (0.133) -0.027 (0.071) 0.573 (0.098) 0.596 (0.090) -0.009 (0.099) 0.11 0.294 
Swing Time Variability (ms) 22.8 (12.6) 21.1 (13.5) 2.1 (11.9) 28.0 (29.6) 24.5 (23.2) 1.8 (20.2) 0.09 0.422 
Rhythm Domain         
Step Time (ms) 580.0 (67.0) 558.5 (100.0) 17.9 (53.4) 593.6 (162.8) 572.1 (111.3) 33.6 (75.8) -0.03 0.802 
Swing Time (ms) 399.2 (61.0) 393.3 (95.5) 1.3 (45.3) 403.8 (104.6) 406.4 (81.5) -1.6 (45.9) 0.02 0.822 
Stance Time (ms) 750.8 (151.7) 732.8 (162.6) 35.7 (79.8) 773.6 (255.0) 757.3 (167.3) 16.3 (123.9) -0.05 0.656 
Variability Domain         
Step Velocity Variability (m/s) 0.072 (0.030) 0.065 (0.033) 0.007 (0.037) 0.076 (0.028) 0.070 (0.028) 0.005 (0.026) -0.00 0.990 
Step Length Variability (m) 0.033 (0.016) 0.028 (0.016) 0.002 (0.012) 0.034 (0.017) 0.033 (0.018) 0.001 (0.016) 0.00 0.990 
Step Time Variability (ms) 31.6 (20.8) 23.8 (20.8) 1.9 (17.0) 33.1 (40.1) 33.3 (28.7) 2.0 (23.2) 0.06 0.607 
Stance Time Variability (ms) 41.8 (32.1) 28.0 (33.0) 2.9 (23.3.) 43.2 (49.5) 41.0 (50.2) 4.0 (28.6) 0.04 0.725 
Asymmetry Domain         
Swing Time Asymmetry (ms) 11.8 (18.1) 12.0 (18.1) -2.1 (18.9) 12.9 (27.4) 13.0 (21.5) 1.9 (19.3) 0.14 0.184 
Step Time Asymmetry (ms) 16.9 (22.6) 13.2 (21.4) 2.3 (18.9) 22.6 (37.3) 20.7 (29.5) 0.5 (27.5) 0.02 0.862 
Stance Time Asymmetry (ms) 13.0 (22.7) 16.1 (17.3) -1.5 (16.6) 16.6 (25.6) 12.5 (25.8) 3.3 (14.8) 0.19 0.070 
Postural Control Domain         
Step Length Asymmetry (m) 0.033 (0.028) 0.029 (0.031) 0.005 (0.025) 0.024 (0.041) 0.025 (0.036) 0.000 (0.022) -0.09 0.379 
Step Width (m) 0.096 (0.041) 0.103 (0.036) -0.000 (0.016) 0.089 (0.050) 0.085 (0.039) 0.004 (0.014) 0.22 0.046 
Step Width Variability (m) 0.018 (0.010) 0.017 (0.011) -0.001 (0.006) 0.018 (0.008) 0.018 (0.008) -0.001 (0.006) -0.02 0.842 
Abbreviations: IQR= Inter quartile range; m/s=meters per second; m=meters; ms=milliseconds; 
a 
Cohens r, non-parametric effect-size, computed using the following formula: r= 
z/√number of observations. bMann-Whitney U test to determine between-group differences (i.e., computed as the difference between follow-up and baseline performance). Bold = 
statistical significance (p < 0.05).  
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6 DISCUSSION 
 
6.1 OVERALL FINDINGS 
The results derived from the psychometric part of this thesis were that the reproducibility of 
the Mini-BESTest was found to be good with regards to reliability, when assessed in a 
clinical setting. However, the measurement error of this instrument showed mixed results. 
Whereas it was considered acceptable when applied on a group level, it was consider high on 
an individual level. Moreover, since the results of the Mini-BESTest were in line with the 
hypotheses (except from its inability to distinguish between recurrent and non-recurrent 
fallers) the construct validity was found to be adequate in PwPD with mild to moderate 
disease severity.  
The results from the intervention part showed that, compared to the control group, the 
training group significantly improved balance and gait performance during single-task 
conditions. On the other hand, the training programme did not improve any gait parameter 
during the dual-task condition, which also explains why the dual-task interference, i.e. gait 
automaticity, was not improved. Conversely, the performance of the added task was 
improved, both with regards to cognitive performance and cognitive performance variability 
during the dual-task gait conditions. Since this did not occur when this task was performed as 
a single-task, this suggests that these improvements were not due to a learning bias, and also 
explains why the dual- task interference was improved following training.    
 
6.2 THE PSYCHOMETRIC PROPERTIES OF THE MINI-BESTEST 
The Mini-BESTest was initially introduced as a more user-friendly version of the BESTest.
23
 
However, while the BESTest was a theoretically anchored test, the items included in the 
Mini-BESTest were predominately derived from statistical analyses.
132
 This resulted in a 
theoretically somewhat ambiguous test
133
 considered to measure the unidimensional and 
undefined construct of dynamic balance, indicating that only the total score of the Mini-
BESTest should be considered. However, similar to the original BESTest, the Mini-BESTest 
clearly identifies four underlying domains and encourages the sub-scoring of these 
domains.
134
  This could be interpreted as if each subcomponent may be investigated 
separately, which has been performed in recent studies.
75,179,180
  
From a clinical perspective, although all items related to two of the subdomains of the 
original BESTest have been omitted, the Mini-BESTest still encompasses relevant items that 
other common multi-item balance tests (such as the Bergs Balance Scale
181
 or the Tinetti 
balance assessment tool)
182
 are lacking. Particularly the postural responses domain may be 
vital to assess in any individual with balance deficiencies, let alone PwPD. Although falling 
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is multifactorial
19
 and its direct link to balance abilities is moderate,
183
 it may be argued that 
the most devastating effects of impaired balance are the risks of injurious falls.
184
 As such, 
the ability to react in order to regain balance following an irreparable perturbation appears to 
be essential for the avoidance of falling. Indeed, previous studies in PwPD have found items 
from the subcomponent postural responses to be significantly associated with falling.
75,180
 
Whereas the performance of this subcomponent did not differ between recurrent and non-
recurrent fallers in this thesis (i.e. paper II); postural responses was the subcomponent that 
distinguished most clearly between PwPD with mild versus moderate disease severity, as 
illustrated by the large effect size (although closely followed by ApA’s).  
Postural responses also signify the subcomponent with the largest proportional measurement 
error. This has also been identified in a similar study albeit on another population.
127
 
Conversely, sensory orientation was the subcomponent with the lowest error. This may 
highlight a relevant issue when interpreting the results of clinical assessment tools. Namely 
that of the potential trade-off between clinically relevant tests that may be accompanied with 
a larger measurement error, while having the potential to provide important information; 
versus tests or items that are easier to reproduce but that may not be as relevant. Indeed, in 
this thesis it is evident that the subcomponent with the smallest measurement error, sensory 
orientation, provides little information of value due to its ceiling effect in this sample, (this is 
illustrated in Figure 5). This ceiling effect is likely the explanation to why sensory orientation 
was the only subcomponent unable to distinguish between PwPD with mild and moderate 
disease severity, a finding that limits its validity in this population. In summary, when 
investigating psychometric properties of clinical tools, it may be advisable to reflect upon the 
perceived clinical value in relation to the measurement properties, where it may be argued 
that a larger measurement error could be accepted for a tool with the potential to reveal 
important information, such as increased risk of falling.     
The ceiling effect found for sensory orientation may be surprising since PwPD have 
frequently demonstrated deficient sensory integration
81,82
 (which also was the reason to why 
the HiBalance programme specifically addressed this aspect of balance).
3
 However, the 
answer to this is likely related to the fact that impaired sensory orientation is usually detected 
by means of posturography (i.e. body sway),
185
 whereas in the Mini-BESTest, the body sway 
is disregarded of. This issue was actually brought up as a potential shortcoming when the 
BESTest was first presented.
23
 Therefore, it is suggested that measures are taken to increase 
the sensitivity of this subcomponent when assessed in clinical practice.  
The findings in this thesis show that the Mini-BESTest is by no means flawless. 
Nevertheless, the overall apprehension is that the test encompasses items of clinical relevance 
for PwPD, which similar multi-item tests are missing. Moreover, although the measurement 
error on individual level was considered high, it is similar to the measurement error of, for 
example, the Bergs balance scale.
126
 Since the Bergs balance scale have been frequently 
reported to have a ceiling effect in this population,
126,128,186
 it may be argued that the Mini-
BESTest overall encompasses sensitive items, more relevant for PwPD, and therefore have a 
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higher clinical value. Therefore it is suggested for clinicians to use the Mini-BESTest in 
PwPD with mild to moderate disease severity, however when doing so, they need to relate 
their findings to the measurement error when evaluating the results.  
Moreover, the reliability of the Mini-BESTest was considered to be good for the total score 
as well as for all subcomponents (except sensory orientation) when administered by the same 
rater. In contrast, when comparing the results between different raters, only the total score 
and the subcomponent APA were found to be good, despite the measures taken on 
beforehand (i.e. training sessions) to synchronise the interpretation pf performance. Similar 
results were found with regards to the proportional measurement error, which may highlight 
the challenges to interpret results found from assessments by different raters in clinical 
practice, particularly with regards to subcomponent scores. The difference with regards to the 
total score was marginal. Therefore, while it is always recommendable that the same clinician 
perform all assessments in a single subject to as large an extent as possible, this appear 
particularly important when evaluating rehabilitation periods with regards to the effects of the 
subcomponents.     
Finally, the measurement error was considered large on an individual level, even when the 
same rater administers all tests. However, when transforming the measurement error on 
individual level to a group level error, the measurement error becomes reasonable. This, in 
combination with the overall adequacy of the construct validity of this test, makes the Mini-
BESTest an appropriate outcome measure in future research; whereas, as of present, the 
Mini-BESTest cannot be recommended to identify fallers with mild to moderate PD.  
    
6.3  THE HIBALANCE INTERVENTION 
At large, the contents of the HiBalance programme corresponded to the subdomains of 
balance as presented by Horak et al.
23
 Therefore it is encouraging that training not only 
improved the overall performance of dynamic balance (i.e. the Mini-BESTest), but that all 
the Mini-BESTest’s subcomponents were improved beyond the measurement error, with the 
exception of sensory orientation. Indeed, the subcomponents APA’s, dynamic gait, and 
sensory orientation were specifically addressed through the programme’s training 
components. However, although postural responses were not addressed by means of a 
specific training component, the concept of being highly challenging relied upon the 
intermittent evocation of reactive responses throughout the entire intervention. It is therefore 
possible that this was not only an important factor for ensuring an appropriate difficulty level, 
but that it also was an important ingredient for promoting reactive abilities. Indeed, the 
recurrent postural responses during training, which consisted of taking compensatory steps in 
order to regain balance control, might have encouraged stepping strategies among the 
participant in the training group. This training characteristic, as well as its findings, 
corresponds with a recent study that promoted a stepping strategy during training in order to 
improve postural responses in PwPD.
187
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Another potentially important aspect of the results of training was how feed-back was 
delivered from the trainers. As stated in the study protocol,
3
 feed-back was aimed to induce 
an external rather than an internal focus, that is, focus on the environment (for example, “step 
over those obstacles”) rather than on the coordination of specific body parts (i.e. “walk with 
longer steps”). This approach was in line with the concepts of a recent model, the optimal 
theory, that highlights the importance of external focus and intrinsic motivation for 
optimizing motor learning.
188
 
A particularly intriguing finding from this intervention was that the training group improved 
several aspects of ST-gait, whereas the DT-gait performance was unaffected in comparison to 
the controls (with the exception of the increased step width among the controls). Instead, the 
training group significantly improved the performance of the added cognitive task during the 
DT-condition (both with regards to cognitive performance and cognitive performance 
variability), but not during the ST-condition. These findings were in stark contrast to what 
has generally been found in pilot studies investigating the effects of DT-training in PwPD. 
Indeed, those studies have generally found improved gait during the DT-condition,
110,111,114
 
whereas improvements of ST-gait
112,116
 or the added task are more uncommon.
112,113
 There 
are likely several factors that contribute to the different results found here, but one factor may 
be embedded in the different design of the interventions. Unlike the majority of the 
previously mentioned studies, the HiBalance intervention did not focus entirely on DT-
training, rather the ST-training played as large a part. It is possible that it is important to 
emphasise DT-gait more than ST-gait in order to achieve DT-specific gait improvements. 
Since a randomised controlled trial with such a design is underway,
189
 it will be relevant to 
compare the results from our study with those upcoming findings in order to pinpoint 
potentially important training ingredients. Nevertheless, the rationale behind the mixture 
between ST and DT-training in this study was that although the importance of adequate DT-
gait abilities have received increased attention in recent years, the importance of improving 
aspects of ST-gait, such as velocity cannot be overestimated due to its established impact on 
general health.
26,27
 Hence, it was essential for the training programme that potential DT-
improvements did not occur at the expense of ST-abilities. On the other hand, ST-step 
velocity has been found to be the strongest predictor for DT-step velocity.
190
 In turn, this may 
indicate that improved ST-step velocity could have the potential to be accompanied by 
improved DT-step velocity. Although that possibly occurred to a limited extent in this study 
(since the DTI of step velocity was one of few gait parameters that showed a tendency to be 
improved in the training group, as compared to the controls, Figure 6), both the small 
magnitude of effect size and lack of significance undermines the impact of improved ST-
velocity for DT-gait improvements.  
It may be important to relate to the patterns of ST-gait and DT-gait, as well as to the results of 
the cognitive task when aspiring to interpret the DTI results. Although there is a lack of 
statistical significance with regards to the DTI gait results, as shown in Figure 6, the effect 
sizes as may reveal underlying patterns in the two groups. Indeed, the effect sizes are of small 
magnitude, nevertheless their direction may indicate a general tendency towards improved 
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DTI of gait in the control group, whereas the training group show the largest improvements 
for cognitive performance and cognitive performance variability. These subtle findings may 
be indicators of allocation strategies in the two groups, wherein the training group; a tendency 
might be discerned that the performance of the cognitive task was performed at the expense 
of DT-gait, and vice versa in the control group.  
In order to optimise allocation strategies, it has been suggested for DT-training to emphasise 
a variety of allocation strategies during DT-training. Examples of this entail alternating 
between which tasks to prioritise: the motor task, the added task, or both.
51,113
 This approach 
has been investigated in a pilot study among PwPD, which resulted in improvements of gait 
parameters related to the pace and variability domains, whereas the added cognitive task was 
unaffected.
114
 In the HiBalance intervention, gait and the added tasks were always instructed 
to be equally prioritised. Therefore it was particularly interesting that the training group 
appeared to prioritise the cognitive task rather than the gait during the DT-condition at 
follow-up. This may seem extra puzzling since they also improved the balance and ST-gait 
performance. However, by relating these findings to a recently proposed model of task 
prioritisation during gait,
49
 this can, arguably, be partly explicated. This model suggests that 
individuals with adequate postural reserves (for example balance or gait abilities) will always 
prioritise the added task when the postural threat (e.g. the perceived risk of physical harm, 
such as falling) is considered to be low. However, when the environment becomes more 
challenging, thereby increasing the postural threat, the attention is allocated from the added 
task towards the walking. At the follow-up assessment in this intervention, the training group 
performed at similar or higher levels than what has been reported for age matched, healthy 
people, both with regards to dynamic balance performance
191
 and ST-gait velocity
25,36
 (i.e. 
mean Mini-BESTest score=22.2 points; mean ST-gait velocity=1.28 m/s). Therefore it is 
possible that they did not perceive the DT-gait condition as a postural threat, but rather 
considered the added task as to be the more challenging situation and therefore allocated the 
attention there. Indeed, the training group had repeatedly performed DT-gait training in more 
environmentally challenging situations (e.g. walking on foam surfaces and negotiating 
obstacles etcetera), hence it would be understandable if they did not perceive the over-ground 
walking upon a flat GaitRITE mat as a postural threat.  
In summary, the findings from HiBalance intervention are encouraging and add support to the 
existing studies showing improved gait and balance performance following training in 
PwPD.
118
 However, more research is needed in order to establish if certain training 
characteristics might be superior to others; and in such a case, implement the successful 
training characteristics into clinical practice. Moreover, it may also be of relevance to 
investigate if individual traits in PwPD (for example cognitive abilities)
192,193
 can predict the 
likelihood to benefit from training. In addition, although this thesis showed a tendency 
towards improved processing automaticity of the added task following DT-training, this 
finding needs to be supported by more evidence. Future studies also need to investigate if it is 
possible to improve gait automaticity following training, and if attention allocation strategies 
can be influenced in this population. 
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6.4  INTERNAL VALIDITY 
Internal validity reflects to what extent research findings can be considered to be true 
reflections of reality, rather than dependent upon external factors. Among the threats to 
internal validity are: participant selection, group allocation, instrumentation and testing 
procedure.  
6.4.1.1 Participant selection and group allocation 
One major threat to internal validity is related to the group compositions. That is, do the 
groups differ with regards to important characteristics such as: age, gender, disease severity, 
medication, physical or cognitive function? The major advantage with performing a 
randomised controlled trial is that, if correctly handled, the randomisation of participants is 
likely to lead to an even distribution of important characteristics in all groups. In this study, 
block randomisation was used in blocks of four. This means that within each block two 
participants were allocated to the training group and two people were allocated to the control 
group. This is an adequate approach in the sense that it will ensure an even balance with the 
regards to the number of participants allocated to each group.
194
 However, like all 
randomisation methods it also has some disadvantages. Indeed, although both the test 
assessors and the participants were blinded to group allocation until the included participant 
had opened the sealed opaque envelope, in theory, the use of fixed block sizes may enable the 
predictions of group allocation towards the end of each block.
195
 Indeed, it has been 
suggested that there is a risk that the use of block randomisations might cause an imbalance 
between groups with regards to covariates. Nevertheless, block randomisation have been 
recommended for trials including up to 100 participants, and in this study no covariates were 
found to significantly differ between the groups (Table II). 
 
6.4.1.2 Instrumentation and testing 
In order to obtain internal validity with regards to the instrumentation used (i.e. the outcome 
measures), the psychometric properties needs to be acceptable. The psychometric properties 
of all outcome measures used in this thesis have been found acceptable. However, apart from 
the instrumentation, certain measures also need to be undertaken with regards to the 
standardisation of test assessors in order to increase the internal validity. In this study, all test 
assessors participated in training prior to the commencement of the study. This training 
included: theoretical discussions regarding the principles of the instrumentation, a 
synchronised view on how to rate the test performance, and practical training, including 
training on how to instruct the participants. Such measures were undertaken in order to 
minimise the risk of learning bias amongst the more inexperienced raters and discrepancies 
between raters and test occasions.
196
 Moreover, during the assessments, a standardised 
scheme was followed in order to minimise learning bias amongst the participants. In addition, 
since the assessment sessions were quite extensive, there was a risk that fatigue might affect 
the performance of the tests performed towards the end of this session. Hence, all participants 
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were requested to take a seated rest midway through the test sessions. Moreover, to avoid a 
systematic bias, all tests were performed in a randomised order.  
One threat to the internal validity of this intervention was that the test assessors were not 
blinded to group allocation at follow-up. Since randomised controlled trials pose a variety of 
logistic challenges, some test assessors also served as trainers. In an effort to limit this 
shortcoming, the participants were never assessed by an individual that had been involved in 
their training. 
Finally, medication play an important part to reduce motor symptoms amongst PwPD, hence 
all participants were tested when optimally medicated (i.e. during the ON phase of the 
medication cycle). Since this population also commonly experience motor fluctuations of 
variable magnitude at different times of the day, all repeated tests were performed at the same 
time of the day. Although the participants were instructed not to change their medication 
dosage during the intervention, this nevertheless occurred among some participants. 
However, there were no significant differences between the training group and the control 
group with respect to change of medicament dosage. 
     
6.5  EXTERNAL VALIDITY 
External validity entails to what extent the findings from a specific study are generalisable to 
a broader spectra. With regards to the contents of this particular thesis, the sample, the 
trainers and the training programme is discussed in relation to external validity.  
6.5.1.1 External validity of the sample  
This study only included PwPD with a mild to moderate disease severity, hence the results 
found here can only be generalised to this specific population. Moreover, the recruitment 
process involved the advertisements in newspapers, where interested PwPD had to contact us. 
Therefore, it is likely that only PwPD motivated in participating in highly challenging gait 
and balance training were included. Since neuropsychiatric symptoms such as depression and 
lack of motivation are common among PwPD,
197-199
 it is likely that the PwPD with such 
symptoms did not report interest for the study. Moreover, based on the MMSE,
156
 we 
excluded participants with signs of cognitive impairment which limits the ecological validity 
of these findings, since PwPD with these symptoms constitutes a substantial portion of 
PwPD.
200
 Indeed, although the included PwPD had a clinical diagnosis and a mild to 
moderate disease severity, their mean single-task gait velocity at baseline was well beyond 
one meter per second, which is a common cut-off to identify healthy older individuals.
25
 
Moreover, according to a recent categorisation of severity of balance problems based on the 
Mini-BESTest performance,
201
 at baseline, the majority of the included participants had 
moderate balance deficits. On the other hand, nearly 50 percent of this sample could also be 
categorised as recurrent fallers.   
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6.5.1.2 External validity of the trainers 
All trainers (n=12) of this intervention were trained physiotherapists currently working at a 
university hospital. The trainers’ clinical experience from neurological rehabilitation ranged 
from 1 to 20 years. It was an equal distribution of male and female trainers. Since the results 
showed that there were no differences in improvements between the groups that had been 
supervised by the different trainers (i.e. during the different semesters and at the different 
geographical sites), this indicates that the results derived from this study were not dependent 
upon individual trainers. Moreover, it may indicate that the theoretical and practical training 
sessions undertaken prior to training were more important than the trainers’ clinical 
experience.  
 
6.5.1.3 External validity of the findings of the intervention 
One aspect of external validity lays in the reproducibility of studies. Important for this 
training programme was that it was a mixture between controlled and uncontrolled 
ingredients. Whereas it was controlled in the sense that specific balance components were to 
be addressed following a structured scheme, it was uncontrolled in the sense that the trainers 
had the freedom to choose and design any kind of exercise within the specific domains. This 
kind of dynamic approach may be particularly beneficial for group training interventions 
since it might make it easier to adapt the training to the abilities of the specific group, both 
with regards to the difficulty level and the feasibility of the specific exercises. Indeed, within 
each geographical cohort, the group compositions were based upon the degree of the 
participants’ gait and balance deficiencies (as perceived by the test assessors). Had the 
training instead used predetermined exercises (i.e. a “cookbook” approach) throughout the 
programme, it might have required participants with very homogenous symptoms in order to 
optimise the challenge level. This is seldom the case among PwPD given the heterogeneity of 
symptoms related to this disease.
202,203
 However, the downside with the approach used in this 
intervention is that it may be difficult to replicate, which may reduce the external validity. On 
the other hand, the reasoning behind this approach was that it was similar to clinical practice 
and can therefore be argued to increase the ecological validity of the study. In addition, the 
within-training group analysis showed that there were no differences in improvements 
between the groups that had participated in training at different time periods (i.e. between 
2012 and 2013), or at the different geographical sites. Since this training was performed by 
physiotherapists working at a hospital, different trainers were involved in the training at 
different time periods due to external reasons (for example change of responsibilities or jobs). 
Hence these findings may incline the arguments that the effects of training were more likely 
to depend upon the training programme, rather than on the trainers or the time that training 
took place.   
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6.6 IMPLICATIONS FOR CLINICAL PRACTICE 
 
 
 Since the proportional measurement error of the Mini-BESTest is similar to other 
common multi-item balance tests-it is recommended to use for balance assessments in 
this population due to its higher clinical relevance. 
 
 
 The Mini-BEST adequately distinguishes between people with Parkinson’s disease 
with mild and moderate disease severity, but should not be used to identify fallers in 
this population.  
 
 
 The subcomponents of the Mini-BESTest with, arguably, the highest clinical value 
also have the largest measurement error; therefore it is advisable to practice these 
items extra carefully before using the test in people with Parkinson’s disease. 
 
 
 The same person should administer the Mini-BESTest before and after a treatment 
period in order to decrease the measurement error, particularly when assessing the 
subcomponents; however it is advisable to have regular training sessions between 
administrators in order to synchronise the evaluation of patients. 
 
 
 Challenging gait and balance training can be successfully conducted in groups of 
people with mild to moderate Parkinson’s disease, thereby increasing treatment 
efficiency. 
 
 
 When conducting dual-task gait training with an added cognitive task, it is important 
to consider the performance of both tasks, as well as the difficulty level of either task. 
In addition, it may also be of importance for clinicians to decide on beforehand what 
aspect of dual-task abilities is most important to improve (i.e. gait, the added task or 
both) and design training accordingly.   
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6.7  SUGGESTIONS FOR FUTURE RESEARCH 
 
 
 Future studies needs to investigate if the Mini-BESTest’s measurement error can be 
reduced when used in people with Parkinson’s disease, for example by clearer 
instructions and increments. 
 
 
 It needs to be established how to relate to the subcomponents of the Mini-BESTest, 
that is, if only the total score should be considered or if it has an added value to also 
investigate the subcomponents separately.  
 
 
 Future studies needs to investigate if highly challenging gait and balance training 
have an added value over moderately challenging training in people with Parkinson’s 
disease. 
 
 
 It would be of value if future studies might identify individual traits that predict 
training outcomes in people with Parkinson’s disease, such as cognitive status.192  
 
 
 It needs to be investigated if training can affect strategies regarding the allocation of 
attention in people with Parkinson’s disease, and if so, what strategies that are 
preferable. 
 
 
 The added cognitive task used in dual-task interventions needs to be thoroughly 
investigated. That is, with regards to how well it reflects everyday function, what its 
potential improvement actually means, and what type task is ideally used (for 
example, which cognitive domains should the task represent and at what difficulty 
level). 
 
 
 Future studies are also recommended to investigate if gait automaticity is possible to 
improve by means of dual-task gait training in people with Parkinson’s disease. 
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7 CONCLUSIONS 
 
 
 The Mini-BESTest can be recommended for use in research due to its validity, 
reliability and agreement on group level. 
 
 
 
 The Mini-BESTest is not able to identify recurrent fallers with mild to moderate 
Parkinson’s disease 
 
 
 
 Highly challenging gait and balance training can improve balance abilities in people 
with Parkinson’s disease with mild to moderate disease severity. 
 
 
 
 Highly challenging gait and balance training in people with Parkinson’s disease 
appears to primarily improve single-task gait abilities related to pace and rhythmicity.  
 
 
 
 It remains unclear if highly challenging gait and balance training can improve 
absolute dual-task gait abilities in people with Parkinson’s disease. 
 
 
  Highly challenging gait and balance training including both single and dual-task 
conditions can improve the dual-task interference of cognitive performance as well as 
cognitive performance variability in people with Parkinson’s disease. 
 
 
 
 
 
  61 
8 ACKNOWLEDGEMENTS 
 
Here, at the roads end, it is about time to give credit to some people that deserve it! Therefore 
I want to thank the following: 
The participants 
First of all I would like to thank all the participants with Parkinson’s disease that reported 
interest to participate in this project. Without your willingness to participate in research, it 
would be difficult to draw conclusions about the adequacy of treatments or measurement 
instruments. I sincerely hope that the findings from this thesis will prove useful for you as 
you continue to battle this disease.  
I would also like to thank all the included participants for your impressive adherence to all 
the training and test sessions throughout these years, I know that some of you had to travel 
long distances, put other things aside,  and overall put in a lot of effort to be able to 
participate. You Rock! 
I also want to thank the participants in the healthy elderly control group, it is important to 
have reference material to compare to when trying to investigate the impact of pathology. 
A special thanks will also be sent to the participants of the pilot study: Dagmar,  Sven, Göte, 
Hans and Kjell. You showed great patience and effort in undertaking a variety of new and 
complicated exercise-combinations, most of which that worked out good but some that went 
into the bin. Your participation and feed-back, positive as negative, was extremely valuable 
for the development of the training programme.  
Last but not least would I like to thank George W Bois for graciously participating in the 
photo shoot, which led to the pics of the Mini-BESTest, and who also pose on the cover of 
this thesis. Thank you for allowing me to use this material! 
 
The supervisors and mentor 
Erika Franzén, main supervisor, for giving me the opportunity to become a PhD student in 
the first place, for the guidance throughout the years, for being responsive to alternative ideas 
and for letting me grow my independence. The door to your office was seldom closed and 
your phone was seldom turned off when I had some spontaneous idea to discuss. Despite the 
occasional difference in opinion, you endured and handled my (apparently)
204
 somewhat 
deviant personality constructively throughout these years. You also showed an appreciable 
amount of trust to my abilities to finish this thesis in time despite the time constraints. Finally, 
I will always be grateful for your great understanding during the times of adverse events in 
my private life, times when my attention primarily were allocated to family matters. 
 62 
Agneta Ståhle, co-supervisor, for giving me the opportunity to become a PhD student, for 
integrating me into your research group, and for giving constructive feed-back on my work; 
despite our difference in opinion regarding how to use the semi-colon. Also, for being an 
encouraging person, full of positive energy.  
Åsa Dedering, mentor, for always encouraging me and thereby enlightening me of the 
benefits of having a mentor throughout this time. Initially, I had no idea what that was going 
to be good for, however I quickly became aware of its advantages after meeting with you for 
this purpose. Despite your hectic schedule, you always set off time to meet with me when I 
asked for it (not seldom with short notice). You were a great listener, constantly giving 
insightful and uplifting advice. I was always full of energy after our meetings, ready to take 
on any challenge (and it did not hurt that you are a fellow Hässelbyare). I am extremely glad 
that I had the opportunity to have you as my mentor. I cannot imagine anyone better suited 
for this.   
 
The Division of Physiotherapy, Karolinska Institutet.  
Thank you to the division of physiotherapy for upgrading a former bachelor student to 
become a doctoral one. 
Maria Hagströmer, head of the division of physiotherapy and co-author, for always giving a 
big picture perspective on things, small as large. 
Anette Heijne, former head of the division of physiotherapy, for being such an enthusiastic 
personality, full of positive energy and never afraid of delivering or take joke. I hope you get 
well soon! I promise to tap dance for you when you’re back!    
Balbir Dhuper, administrator, for helping out with all sorts of things throughout these years. 
Not least for helping me get access to the facilities every time someone’s stolen my card 
(why does that always happen to me?). 
Vanja Landin, former financial person, for all the extensive help with invoices and other 
things throughout these years, I don’t know how to make it without you going forward. 
Johanna, for covering for my inabilities to put numerous used coffee cups into the 
dishwasher. Everything collapses when you are on vacation.   
 
 
 
 
 
  63 
The colleagues of the BETA-PD project 
Breiffni Leavy, in particular for great constructive feedback on the discussion part of this 
thesis, I’ll try to take a clearer stance. Also for being an uplifting addition to this team, with a 
nice, wry, sense of humour. 
Kirsti Skavberg Roaldsen, for being a positive and encouraging person, who also adds some 
qualitative views of things. 
Martin Benka Wallén, co-author, for extensive, sometime feisty (but that’s just refreshing), 
discussions on psychometrics and statistics. 
Linda Rennie, co-author, for good feedback, being a pleasant person and for sharing articles. 
Not least for looking after my daughter for a short while so I could get a bathroom-break 
when I brought her to work.  
Lisbet Broman, for always being a nice person (unlike me), willing to help out with just 
about anything, and also with the roots in Hässelby. 
 
PhD student colleagues  
David Conradsson (also known as” broder duktig”, or “the favourite”), project twin, 
fellow research off-spring of Björn Äng. For great support and collaboration throughout these 
years on and off the “ice”. For helping out with graphic stuff, for giving great feed-back, and 
for being the occasional pain in the %!#&, which could be frustrating at times but almost 
always triggered sharpened argumentation. As a representative of the concept premature 
aging,
205
 you are probably one of the oldest 31 year olds in the world (the fact that you 
actually listen to something called white noise, apparently not a group, during the days must 
be a pathological sign- check it up!). Nevertheless, you are person without whom these past 
years would have been a lot less creative and enjoyable. 
Conran Joseph, an international addition to the homogenous group of PhD students at the 
division of physiotherapy, for letting me integrate you into the Swedish society by means of 
moving furniture, repeatedly. This is one of the most honourable situations to share, since 
then we are knit together forever! Also thanks for lighting up my afternoons with that comedy 
stint of yours, where you talk with pretentious words for a few minutes without saying 
anything concrete, and actually act as you´re seriously trying to make an important point. 
That has been fantastic! Also thanks for all the editing! 
Håkan Nero, PhD student and co-author, for good discussions and feed-back, giving 
perspective of things; and for being a nice guy to hang out with.   
Andreas Monnier, PhD student and fellow evening worker, for great discussions, scientific 
as real-world related. For engaging so passionately in important questions such as “what type 
of coffee machine do we need”.   
 64 
Emelie Karlsson, PhD student, for always being a friendly face, never reluctant to give quick 
feed-back. A great contributor of good atmosphere at work. 
Björn Äng, former supervisor, for luring me into research (I don’t know if I should thank 
you or accuse you here). For having planted a seed, that apparently still grows (this sounded a 
bit pretentious…). Also for being a caring person to discuss life events with, and who 
introduced me to mini-tennis (or tennis as you call it). Also thank you for leading the way 
when it comes to using sport tights in public. 
Wim Grooten, PhD, bohemian and musical genius, for being a clever, chaotic and fun 
person to interact with. You´re always helpful and ask tricky questions, sometimes I feel the 
urge to carry you around though.  
Lena Nilsson-Wikmar, PhD, for being a positive person with a funny accent. It was always 
enjoyable to discuss with you, as well as to” throw jaws”. 
Sverker Johansson, PhD, head of the section of Neurology at Karolinska University 
Hospital, for asking intelligent questions, positive energy, and for sharing your concerns 
regarding what sort of dog to buy (go for a beagle).  
 
International influences 
Rolf-Moe Nilssen, senior researcher at the University of Bergen, for showing great 
hospitality and endless willingness of discussing research methodology. Your course 
regarding psychometric properties was extremely influential for my developments regarding 
this area! 
 Alice Nieuwboer and her research group at KU Leuven, Belgium, for showing great 
hospitality to both me and my family during our month in Leuven, for graciously integrating 
me into the research group, and for the willingness to discuss just about anything in good 
spirit.    
 
The trainers at Karolinska University hospital 
Sebastian Lindblom, physiotherapist, soon to be PhD student for some reason, for being an 
influential part in the development of the training programme, for being a good representative 
of Hässelby, for helping me move, for not being able to score on me when we played floor 
ball, and despite being a Hammarby fan. 
Thanks also to the rest of the trainers and testers: Johan Berntsson, Emma Strandberg, Elin 
Farén, Nina Andersson, Sanna Lundqvist, Jörgen Hassler, Nikki Ingvast and Jenny Kamel. 
  65 
Emma Lenholm, co-author and test-assessor, for helping out with the assessments for paper 
I and for being a genuinely nice person. 
 
All the colleagues at Rehab Korpen, Visby lasarett 
It was a great break from research to get back to clinical reality and working with all of you 
during the summer holidays, not least the opportunities to discuss clinical challenges in 
relation to research. 
 
Extra material 
Ken, musician, for all the songs that have helped me cope with stuff during these years 
(particularly the song “Hässelby” and an unmentionable one). 
Klas Ingesson, the great footballer and person, who unfortunately had to die before the 
general population could see what a great player you were. You are forever a role model for 
the constructs of fighting spirit and reluctance to giving up. You´re forever my idol and I 
have never taken the death of a person that I never met harder. By the way, David should 
thank you, the fact that you two are from the same place made me more accepting to some of 
his flaws. 
 
Kids in my surrounding worth mentioning for the sake of it 
Jack, my favourite neighbour, never stop asking questions or tell me things-it’s great! We’ll 
play some more football in the summer I hope (and maybe shoot some pilbåge). 
William, nephew, always full of energy 
Agnes, great footballer and runner  
Noomi, una hija muy divertida 
Selma, one of the cleverest little girls I know, also a potential representative of the construct 
“premature aging”. 
Arvid, a nice and artful boy. 
 
 
 
 
 66 
Family 
Marran, Anders, Malin, Greta, Einar, your help and contributions during this time have 
been extremely appreciated and important for this work to be finished in time. Thank you for 
everything! 
Kasper, cousin, our running trips throughout these years have been highly welcomed 
breathing holes during this time, which have resulted in extra amount of energy when coming 
back. I hope that will continue, but I’ll have to try and persuade Elin first, so don’t say 
anything to her yet. 
Alice & Gunnar Schaffer, my beloved and late grandparents, you are my role models and I 
wish you could have been here now. I will always miss and love you!   
Jorgelina, ahijada, amiga y superestrella, tu fue la luz de mi vida antes del nacimiento de 
Signe. Ahora tengo dos luces pero he pasado demasiado poco tiempo contigo últimamente. 
Voy a tratar de cambiar eso de partir de ahora. Pasar tiempo con la superestrella Jorgelina 
hace la vida muy más divertida!  
Mamma, thank you for all the help during this time, both lately and during the research visit 
in Leuven! This thing would never have been finished in time without all that help. It is easy 
to forget that you actually suffered a stroke, but you should learn to take it easy at times as 
well! You are also probably responsible for me becoming a physiotherapist in the first place, 
with all your rehab talk when I grew up. By the way, I hope this thing makes up for my lack 
grades in school.  
Elin, second best friend and fiancée, without you this work would never have been possible. 
Thank you for accepting the single mother role during the last couple of weeks, I hope to 
repay you shortly- when it’s your turn. Considering the bizarre events that happened during 
the last couple of months, your efforts in completing the half-time and publishing articles, 
while at the same time taking care of Signe single-handily are admirable. You start to look 
like marriage material! By the way, I realise that now is probably not the best time to ask if I 
can go abroad on a trip with Kasper! But is it OK?  
Signe, best friend and daughter, I want start by apologising to you! I am sorry about my 
absence from home the last few weeks. It has been a bizarre period when our only interaction 
during the weeks has been through the nightly skype call. I will try to make sure this kind of 
behaviour never happens again. Nevertheless, a fond memory, characteristic for this period, 
was when I submitted the articles to the examination board in the middle of the night. Then 
you had woken up and refused to be put back to sleep, hence when I tried to compose the e-
mail you sat by my side, trying to touch the keyboard. In that sense, you are highly involved 
in the work with this thesis. From now on I will allocate my attention to you so extensively 
that you will get sick and tired of me. 
 
  67 
9 REFERENCES 
 
1. Anton SD, Woods AJ, Ashizawa T, et al. Successful aging: Advancing the science of 
physical independence in older adults. Ageing research reviews. Nov 2015;24(Pt 
B):304-327. 
2. van Uem JM, Marinus J, Canning C, et al. Health-Related Quality of Life in patients 
with Parkinson's disease-A systematic review based on the ICF model. Neuroscience 
and biobehavioral reviews. Feb 2016;61:26-34. 
3. Conradsson D, Lofgren N, Stahle A, Hagstromer M, Franzen E. A novel conceptual 
framework for balance training in Parkinson's disease-study protocol for a randomised 
controlled trial. BMC neurology. 2012;12:111. 
4. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. The Lancet. 
Neurology. Jun 2006;5(6):525-535. 
5. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor 
features and risk factors for Parkinson disease. Annals of neurology. Dec 
2012;72(6):893-901. 
6. Lokk J, Borg S, Svensson J, Persson U, Ljunggren G. Drug and treatment costs in 
Parkinson's disease patients in Sweden. Acta neurologica Scandinavica. Feb 
2012;125(2):142-147. 
7. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with 
Parkinson disease in the most populous nations, 2005 through 2030. Neurology. Jan 
30 2007;68(5):384-386. 
8. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of 
Parkinson disease (2009). Neurology. May 26 2009;72(21 Suppl 4):S1-136. 
9. Poirier LJ, Sourkes TL. Influence of the Substantia Nigra on the Catecholamine 
Content of the Striatum. Brain : a journal of neurology. Mar 1965;88:181-192. 
10. Bellucci A, Mercuri NB, Venneri A, et al. Review: Parkinson's disease: from synaptic 
loss to connectome dysfunction. Neuropathology and applied neurobiology. Feb 
2016;42(1):77-94. 
11. Jankovic J. Parkinson's disease: clinical features and diagnosis. Journal of neurology, 
neurosurgery, and psychiatry. Apr 2008;79(4):368-376. 
12. Kakkar AK, Dahiya N. Management of Parkinsons disease: Current and future 
pharmacotherapy. European journal of pharmacology. Mar 5 2015;750:74-81. 
13. Dirnberger G, Jahanshahi M. Executive dysfunction in Parkinson's disease: a review. 
Journal of neuropsychology. Sep 2013;7(2):193-224. 
14. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: 
dopaminergic pathophysiology and treatment. The Lancet. Neurology. May 
2009;8(5):464-474. 
15. Rao G, Fisch L, Srinivasan S, et al. Does this patient have Parkinson disease? Jama. 
Jan 15 2003;289(3):347-353. 
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 
May 1967;17(5):427-442. 
 68 
17. Canning CG, Paul SS, Nieuwboer A. Prevention of falls in Parkinson's disease: a 
review of fall risk factors and the role of physical interventions. Neurodegenerative 
disease management. 2014;4(3):203-221. 
18. Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson's disease: a 
systematic review. Parkinson's disease. 2013;2013:906274. 
19. Fasano A, Plotnik M, Bove F, Berardelli A. The neurobiology of falls. Neurological 
sciences : official journal of the Italian Neurological Society and of the Italian Society 
of Clinical Neurophysiology. Dec 2012;33(6):1215-1223. 
20. Adkin AL, Frank JS, Jog MS. Fear of falling and postural control in Parkinson's 
disease. Movement disorders : official journal of the Movement Disorder Society. 
May 2003;18(5):496-502. 
21. Giladi N, Horak FB, Hausdorff JM. Classification of gait disturbances: distinguishing 
between continuous and episodic changes. Movement disorders : official journal of 
the Movement Disorder Society. Sep 15 2013;28(11):1469-1473. 
22. Peterson DS, Horak FB. Neural Control of Walking in People with Parkinsonism. 
Physiology. Mar 2016;31(2):95-107. 
23. Horak FB, Wrisley DM, Frank J. The Balance Evaluation Systems Test (BESTest) to 
differentiate balance deficits. Physical therapy. May 2009;89(5):484-498. 
24. Kikkert LH, Vuillerme N, van Campen JP, Hortobagyi T, Lamoth CJ. Walking ability 
to predict future cognitive decline in old adults: A scoping review. Ageing research 
reviews. Feb 6 2016;27:1-14. 
25. Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a 
predictor of adverse outcomes in community-dwelling older people an International 
Academy on Nutrition and Aging (IANA) Task Force. The journal of nutrition, 
health & aging. Dec 2009;13(10):881-889. 
26. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. Jama. 
Jan 5 2011;305(1):50-58. 
27. Fritz S, Lusardi M. White paper: "walking speed: the sixth vital sign". Journal of 
geriatric physical therapy. 2009;32(2):46-49. 
28. Jahn K, Deutschlander A, Stephan T, et al. Supraspinal locomotor control in 
quadrupeds and humans. Progress in brain research. 2008;171:353-362. 
29. Takakusaki K. Neurophysiology of gait: from the spinal cord to the frontal lobe. 
Movement disorders : official journal of the Movement Disorder Society. Sep 15 
2013;28(11):1483-1491. 
30. Kaneda K, Nambu A, Tokuno H, Takada M. Differential processing patterns of motor 
information via striatopallidal and striatonigral projections. Journal of 
neurophysiology. Sep 2002;88(3):1420-1432. 
31. Johnson MD, Zhang J, Ghosh D, McIntyre CC, Vitek JL. Neural targets for relieving 
parkinsonian rigidity and bradykinesia with pallidal deep brain stimulation. Journal of 
neurophysiology. Jul 2012;108(2):567-577. 
32. Kumar A, Mann S, Sossi V, et al. [11C]DTBZ-PET correlates of levodopa responses 
in asymmetric Parkinson's disease. Brain : a journal of neurology. Dec 2003;126(Pt 
12):2648-2655. 
  69 
33. Hausdorff JM. Gait variability: methods, modeling and meaning. Journal of 
neuroengineering and rehabilitation. 2005;2:19. 
34. Maki BE. Gait changes in older adults: predictors of falls or indicators of fear. 
Journal of the American Geriatrics Society. Mar 1997;45(3):313-320. 
35. Lord S, Galna B, Rochester L. Moving forward on gait measurement: toward a more 
refined approach. Movement disorders : official journal of the Movement Disorder 
Society. Sep 15 2013;28(11):1534-1543. 
36. Hollman JH, McDade EM, Petersen RC. Normative spatiotemporal gait parameters in 
older adults. Gait & posture. May 2011;34(1):111-118. 
37. Lord S, Galna B, Verghese J, Coleman S, Burn D, Rochester L. Independent domains 
of gait in older adults and associated motor and nonmotor attributes: validation of a 
factor analysis approach. The journals of gerontology. Series A, Biological sciences 
and medical sciences. Jul 2013;68(7):820-827. 
38. Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and 
attention in gait. Movement disorders : official journal of the Movement Disorder 
Society. Feb 15 2008;23(3):329-342; quiz 472. 
39. Clark DJ. Automaticity of walking: functional significance, mechanisms, 
measurement and rehabilitation strategies. Frontiers in human neuroscience. 
2015;9:246. 
40. Schneider W, Shiffrin RM. Controlled and automatic human information processing, 
I. Detection, search, and attention. . Psychological Review. 1977;84(1):1-66. 
41. Schneider W. Controlled & automatic processing: behavior, theory, and biological 
mechanisms. Cognitive Science. 2003;27(3):525-559. 
42. McIsaac TL, Lamberg EM, Muratori LM. Building a framework for a dual task 
taxonomy. BioMed research international. 2015;2015:591475. 
43. Rochester L, Galna B, Lord S, Burn D. The nature of dual-task interference during 
gait in incident Parkinson's disease. Neuroscience. Apr 18 2014;265:83-94. 
44. Plummer P, Eskes G. Measuring treatment effects on dual-task performance: a 
framework for research and clinical practice. Frontiers in human neuroscience. 
2015;9:225. 
45. Norman DA, Shallice T. Attention to action: Willed and automatic control of 
behaviour. Vol 4: Consciousness and Self-Regulation: Advances in Research and 
Theory IV; 1986. 
46. Wu T, Hallett M, Chan P. Motor automaticity in Parkinson's disease. Neurobiology of 
disease. Oct 2015;82:226-234. 
47. Shumway-Cook A, Woollacott M, Kerns KA, Baldwin M. The effects of two types of 
cognitive tasks on postural stability in older adults with and without a history of falls. 
The journals of gerontology. Series A, Biological sciences and medical sciences. Jul 
1997;52(4):M232-240. 
48. Bloem BR, Grimbergen YA, van Dijk JG, Munneke M. The "posture second" 
strategy: a review of wrong priorities in Parkinson's disease. Journal of the 
neurological sciences. Oct 25 2006;248(1-2):196-204. 
 70 
49. Yogev-Seligmann G, Hausdorff JM, Giladi N. Do we always prioritize balance when 
walking? Towards an integrated model of task prioritization. Movement disorders : 
official journal of the Movement Disorder Society. May 2012;27(6):765-770. 
50. Kelly VE, Eusterbrock AJ, Shumway-Cook A. The effects of instructions on dual-
task walking and cognitive task performance in people with Parkinson's disease. 
Parkinson's disease. 2012;2012:671261. 
51. Yogev-Seligmann G, Rotem-Galili Y, Dickstein R, Giladi N, Hausdorff JM. Effects 
of explicit prioritization on dual task walking in patients with Parkinson's disease. 
Gait & posture. Apr 2012;35(4):641-646. 
52. Muir-Hunter SW, Wittwer JE. Dual-task testing to predict falls in community-
dwelling older adults: a systematic review. Physiotherapy. Mar 2016;102(1):29-40. 
53. Horak FB. Postural orientation and equilibrium: what do we need to know about 
neural control of balance to prevent falls? Age and ageing. Sep 2006;35 Suppl 2:ii7-
ii11. 
54. Pollock AS, Durward BR, Rowe PJ, Paul JP. What is balance? Clinical rehabilitation. 
Aug 2000;14(4):402-406. 
55. Horak FB, Henry SM, Shumway-Cook A. Postural perturbations: new insights for 
treatment of balance disorders. Physical therapy. May 1997;77(5):517-533. 
56. Horak FB, Frank J, Nutt J. Effects of dopamine on postural control in parkinsonian 
subjects: scaling, set, and tone. Journal of neurophysiology. Jun 1996;75(6):2380-
2396. 
57. Jacobs JV, Dimitrova DM, Nutt JG, Horak FB. Can stooped posture explain 
multidirectional postural instability in patients with Parkinson's disease? Experimental 
brain research. Sep 2005;166(1):78-88. 
58. Holbein MA, Redfern MS. Functional stability limits while holding loads in various 
positions. International journal of industrial ergonomics. May 1997;19(5):387-395. 
59. Horak FB, Dimitrova D, Nutt JG. Direction-specific postural instability in subjects 
with Parkinson's disease. Experimental neurology. Jun 2005;193(2):504-521. 
60. Schieppati M, Nardone A. Free and supported stance in Parkinson's disease. The 
effect of posture and 'postural set' on leg muscle responses to perturbation, and its 
relation to the severity of the disease. Brain : a journal of neurology. Jun 1991;114 ( 
Pt 3):1227-1244. 
61. Massion J. Movement, posture and equilibrium: interaction and coordination. 
Progress in neurobiology. 1992;38(1):35-56. 
62. Aruin AS, Forrest WR, Latash ML. Anticipatory postural adjustments in conditions 
of postural instability. Electroencephalography and clinical neurophysiology. Aug 
1998;109(4):350-359. 
63. Boonstra TA, van Kordelaar J, Engelhart D, van Vugt JP, van der Kooij H. 
Asymmetries in reactive and anticipatory balance control are of similar magnitude in 
Parkinson's disease patients. Gait & posture. Jan 2016;43:108-113. 
64. Lin CC, Creath RA, Rogers MW. Variability of Anticipatory Postural Adjustments 
During Gait Initiation in Individuals With Parkinson Disease. Journal of neurologic 
physical therapy : JNPT. Jan 2016;40(1):40-46. 
  71 
65. King LA, St George RJ, Carlson-Kuhta P, Nutt JG, Horak FB. Preparation for 
compensatory forward stepping in Parkinson's disease. Archives of physical medicine 
and rehabilitation. Sep 2010;91(9):1332-1338. 
66. Jacobs JV, Nutt JG, Carlson-Kuhta P, Stephens M, Horak FB. Knee trembling during 
freezing of gait represents multiple anticipatory postural adjustments. Experimental 
neurology. Feb 2009;215(2):334-341. 
67. Chan CW, Jones GM, Kearney RE, Watt DG. The 'late' electromyographic response 
to limb displacement in man. I. Evidence for supraspinal contribution. 
Electroencephalography and clinical neurophysiology. Feb 1979;46(2):173-181. 
68. Matthews PB. The human stretch reflex and the motor cortex. Trends in 
neurosciences. Mar 1991;14(3):87-91. 
69. Jacobs JV, Horak FB. Cortical control of postural responses. Journal of neural 
transmission. 2007;114(10):1339-1348. 
70. Rinalduzzi S, Trompetto C, Marinelli L, et al. Balance dysfunction in Parkinson's 
disease. BioMed research international. 2015;2015:434683. 
71. Nonnekes J, Oude Nijhuis LB, de Niet M, et al. StartReact restores reaction time in 
HSP: evidence for subcortical release of a motor program. The Journal of 
neuroscience : the official journal of the Society for Neuroscience. Jan 1 
2014;34(1):275-281. 
72. Nonnekes J, Scotti A, Oude Nijhuis LB, et al. Are postural responses to backward and 
forward perturbations processed by different neural circuits? Neuroscience. Aug 15 
2013;245:109-120. 
73. Hely MA, Morris JG, Rail D, et al. The Sydney Multicentre Study of Parkinson's 
disease: a report on the first 3 years. Journal of neurology, neurosurgery, and 
psychiatry. Mar 1989;52(3):324-328. 
74. Kim SD, Allen NE, Canning CG, Fung VS. Postural instability in patients with 
Parkinson's disease. Epidemiology, pathophysiology and management. CNS drugs. 
Feb 2013;27(2):97-112. 
75. Schlenstedt C, Brombacher S, Hartwigsen G, Weisser B, Moller B, Deuschl G. 
Comparison of the Fullerton Advanced Balance Scale, Mini-BESTest, and Berg 
Balance Scale to Predict Falls in Parkinson Disease. Physical therapy. Apr 
2016;96(4):494-501. 
76. Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of gait in 
Parkinson's disease: a review of two interconnected, episodic phenomena. Movement 
disorders : official journal of the Movement Disorder Society. Aug 2004;19(8):871-
884. 
77. Carpenter MG, Allum JH, Honegger F, Adkin AL, Bloem BR. Postural abnormalities 
to multidirectional stance perturbations in Parkinson's disease. Journal of neurology, 
neurosurgery, and psychiatry. Sep 2004;75(9):1245-1254. 
78. Dimitrova D, Horak FB, Nutt JG. Postural muscle responses to multidirectional 
translations in patients with Parkinson's disease. Journal of neurophysiology. Jan 
2004;91(1):489-501. 
79. Peterka RJ. Sensorimotor integration in human postural control. Journal of 
neurophysiology. Sep 2002;88(3):1097-1118. 
 72 
80. Mergner T, Siebold C, Schweigart G, Becker W. Human perception of horizontal 
trunk and head rotation in space during vestibular and neck stimulation. Experimental 
brain research. 1991;85(2):389-404. 
81. Conte A, Khan N, Defazio G, Rothwell JC, Berardelli A. Pathophysiology of 
somatosensory abnormalities in Parkinson disease. Nature reviews. Neurology. Dec 
2013;9(12):687-697. 
82. Stylianou AP, McVey MA, Lyons KE, Pahwa R, Luchies CW. Postural sway in 
patients with mild to moderate Parkinson's disease. The International journal of 
neuroscience. Nov 2011;121(11):614-621. 
83. Mancini M, Horak FB, Zampieri C, Carlson-Kuhta P, Nutt JG, Chiari L. Trunk 
accelerometry reveals postural instability in untreated Parkinson's disease. 
Parkinsonism & related disorders. Aug 2011;17(7):557-562. 
84. Galna B, Murphy AT, Morris ME. Obstacle crossing in people with Parkinson's 
disease: foot clearance and spatiotemporal deficits. Human movement science. Oct 
2010;29(5):843-852. 
85. Stegemoller EL, Buckley TA, Pitsikoulis C, Barthelemy E, Roemmich R, Hass CJ. 
Postural instability and gait impairment during obstacle crossing in Parkinson's 
disease. Archives of physical medicine and rehabilitation. Apr 2012;93(4):703-709. 
86. Yang WC, Hsu WL, Wu RM, Lu TW, Lin KH. Motion analysis of axial rotation and 
gait stability during turning in people with Parkinson's disease. Gait & posture. Feb 
2016;44:83-88. 
87. Stack E, Ashburn A. Fall events described by people with Parkinson's disease: 
implications for clinical interviewing and the research agenda. Physiotherapy 
research international : the journal for researchers and clinicians in physical 
therapy. 1999;4(3):190-200. 
88. Fox SH, Katzenschlager R, Lim SY, et al. The Movement Disorder Society Evidence-
Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's 
disease. Movement disorders : official journal of the Movement Disorder Society. Oct 
2011;26 Suppl 3:S2-41. 
89. Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB. Levodopa Is a Double-
Edged Sword for Balance and Gait in People With Parkinson's Disease. Movement 
disorders : official journal of the Movement Disorder Society. Sep 2015;30(10):1361-
1370. 
90. Calabresi P, Ghiglieri V, Mazzocchetti P, Corbelli I, Picconi B. Levodopa-induced 
plasticity: a double-edged sword in Parkinson's disease? Philosophical transactions of 
the Royal Society of London. Series B, Biological sciences. Jul 5 2015;370(1672). 
91. Hirsch MA, Iyer SS, Sanjak M. Exercise-induced neuroplasticity in human 
Parkinson's disease: What is the evidence telling us? Parkinsonism & related 
disorders. Jan 2016;22 Suppl 1:S78-81. 
92. Abbruzzese G, Marchese R, Avanzino L, Pelosin E. Rehabilitation for Parkinson's 
disease: Current outlook and future challenges. Parkinsonism & related disorders. Jan 
2016;22 Suppl 1:S60-64. 
93. Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no 
intervention in Parkinson's disease. The Cochrane database of systematic reviews. 
2012;8:CD002817. 
  73 
94. Deane KH, Ellis-Hill C, Jones D, et al. Systematic review of paramedical therapies 
for Parkinson's disease. Movement disorders : official journal of the Movement 
Disorder Society. Sep 2002;17(5):984-991. 
95. Bloem BR, de Vries NM, Ebersbach G. Nonpharmacological treatments for patients 
with Parkinson's disease. Movement disorders : official journal of the Movement 
Disorder Society. Sep 15 2015;30(11):1504-1520. 
96. Monteiro-Junior RS, Cevada T, Oliveira BR, et al. We need to move more: 
Neurobiological hypotheses of physical exercise as a treatment for Parkinson's 
disease. Medical hypotheses. Nov 2015;85(5):537-541. 
97. Petzinger GM, Fisher BE, McEwen S, Beeler JA, Walsh JP, Jakowec MW. Exercise-
enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's 
disease. The Lancet. Neurology. Jul 2013;12(7):716-726. 
98. Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ. Neuroprotective 
effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. 
Journal of neurochemistry. Apr 2003;85(2):299-305. 
99. Wu SY, Wang TF, Yu L, et al. Running exercise protects the substantia nigra 
dopaminergic neurons against inflammation-induced degeneration via the activation 
of BDNF signaling pathway. Brain, behavior, and immunity. Jan 2011;25(1):135-146. 
100. Real CC, Ferreira AF, Chaves-Kirsten GP, Torrao AS, Pires RS, Britto LR. BDNF 
receptor blockade hinders the beneficial effects of exercise in a rat model of 
Parkinson's disease. Neuroscience. May 1 2013;237:118-129. 
101. Fisher BE, Wu AD, Salem GJ, et al. The effect of exercise training in improving 
motor performance and corticomotor excitability in people with early Parkinson's 
disease. Archives of physical medicine and rehabilitation. Jul 2008;89(7):1221-1229. 
102. Fisher BE, Li Q, Nacca A, et al. Treadmill exercise elevates striatal dopamine D2 
receptor binding potential in patients with early Parkinson's disease. Neuroreport. Jul 
10 2013;24(10):509-514. 
103. Zoladz JA, Majerczak J, Zeligowska E, et al. Moderate-intensity interval training 
increases serum brain-derived neurotrophic factor level and decreases inflammation 
in Parkinson's disease patients. Journal of physiology and pharmacology : an official 
journal of the Polish Physiological Society. Jun 2014;65(3):441-448. 
104. Marusiak J, Zeligowska E, Mencel J, et al. Interval training-induced alleviation of 
rigidity and hypertonia in patients with Parkinson's disease is accompanied by 
increased basal serum brain-derived neurotrophic factor. Journal of rehabilitation 
medicine. Apr 2015;47(4):372-375. 
105. Frazzitta G, Maestri R, Ghilardi MF, et al. Intensive rehabilitation increases BDNF 
serum levels in parkinsonian patients: a randomized study. Neurorehabilitation and 
neural repair. Feb 2014;28(2):163-168. 
106. Sehm B, Taubert M, Conde V, et al. Structural brain plasticity in Parkinson's disease 
induced by balance training. Neurobiology of aging. Jan 2014;35(1):232-239. 
107. Reuter I, Mehnert S, Leone P, Kaps M, Oechsner M, Engelhardt M. Effects of a 
flexibility and relaxation programme, walking, and nordic walking on Parkinson's 
disease. Journal of aging research. 2011;2011:232473. 
 74 
108. Keus SH, Bloem BR, Hendriks EJ, Bredero-Cohen AB, Munneke M, Practice 
Recommendations Development G. Evidence-based analysis of physical therapy in 
Parkinson's disease with recommendations for practice and research. Movement 
disorders : official journal of the Movement Disorder Society. Mar 15 
2007;22(4):451-460; quiz 600. 
109. Nieuwboer A, Rochester L, Muncks L, Swinnen SP. Motor learning in Parkinson's 
disease: limitations and potential for rehabilitation. Parkinsonism & related disorders. 
Dec 2009;15 Suppl 3:S53-58. 
110. Fritz NE, Cheek FM, Nichols-Larsen DS. Motor-Cognitive Dual-Task Training in 
Persons With Neurologic Disorders: A Systematic Review. Journal of neurologic 
physical therapy : JNPT. Jul 2015;39(3):142-153. 
111. Ginis P, Nieuwboer A, Dorfman M, et al. Feasibility and effects of home-based 
smartphone-delivered automated feedback training for gait in people with Parkinson's 
disease: A pilot randomized controlled trial. Parkinsonism & related disorders. Jan 
2016;22:28-34. 
112. Mirelman A, Maidan I, Herman T, Deutsch JE, Giladi N, Hausdorff JM. Virtual 
reality for gait training: can it induce motor learning to enhance complex walking and 
reduce fall risk in patients with Parkinson's disease? The journals of gerontology. 
Series A, Biological sciences and medical sciences. Feb 2011;66(2):234-240. 
113. Brauer SG, Morris ME. Can people with Parkinson's disease improve dual tasking 
when walking? Gait & posture. Feb 2010;31(2):229-233. 
114. Yogev-Seligmann G, Giladi N, Brozgol M, Hausdorff JM. A training program to 
improve gait while dual tasking in patients with Parkinson's disease: a pilot study. 
Archives of physical medicine and rehabilitation. Jan 2012;93(1):176-181. 
115. Strouwen C, Molenaar EA, Munks L, et al. Dual tasking in Parkinson's disease: 
should we train hazardous behavior? Expert review of neurotherapeutics. 
2015;15(9):1031-1039. 
116. Fok P, Farrell M, McMeeken J. Prioritizing gait in dual-task conditions in people with 
Parkinson's. Human movement science. Oct 2010;29(5):831-842. 
117. Plummer P, Osborne MB. What Are We Attempting to Improve When We Train 
Dual-Task Performance? Journal of neurologic physical therapy : JNPT. Jul 
2015;39(3):154-155. 
118. Klamroth S, Steib S, Devan S, Pfeifer K. Effects of Exercise Therapy on Postural 
Instability in Parkinson Disease: A Meta-analysis. Journal of neurologic physical 
therapy : JNPT. Jan 2016;40(1):3-14. 
119. Tomlinson CL, Herd CP, Clarke CE, et al. Physiotherapy for Parkinson's disease: a 
comparison of techniques. The Cochrane database of systematic reviews. 
2014;6:CD002815. 
120. Paterson K, Hill K, Lythgo N. Stride dynamics, gait variability and prospective falls 
risk in active community dwelling older women. Gait & posture. Feb 
2011;33(2):251-255. 
121. Delval A, Salleron J, Bourriez JL, et al. Kinematic angular parameters in PD: 
reliability of joint angle curves and comparison with healthy subjects. Gait & posture. 
Oct 2008;28(3):495-501. 
  75 
122. Soangra R, Lockhart TE. Comparison of intra individual physiological sway 
complexity from force plate and inertial measurement unit - biomed 2013. Biomedical 
sciences instrumentation. 2013;49:180-186. 
123. Mancini M, Horak FB. The relevance of clinical balance assessment tools to 
differentiate balance deficits. European journal of physical and rehabilitation 
medicine. Jun 2010;46(2):239-248. 
124. de Vet HC, Terwee CB, Knol DL, Bouter LM. When to use agreement versus 
reliability measures. Journal of clinical epidemiology. Oct 2006;59(10):1033-1039. 
125. Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient 
and the SEM. Journal of strength and conditioning research / National Strength & 
Conditioning Association. Feb 2005;19(1):231-240. 
126. Steffen T, Seney M. Test-retest reliability and minimal detectable change on balance 
and ambulation tests, the 36-item short-form health survey, and the unified Parkinson 
disease rating scale in people with parkinsonism. Physical therapy. Jun 
2008;88(6):733-746. 
127. Tsang CS, Liao LR, Chung RC, Pang MY. Psychometric properties of the Mini-
Balance Evaluation Systems Test (Mini-BESTest) in community-dwelling individuals 
with chronic stroke. Physical therapy. Aug 2013;93(8):1102-1115. 
128. Godi M, Franchignoni F, Caligari M, Giordano A, Turcato AM, Nardone A. 
Comparison of reliability, validity, and responsiveness of the mini-BESTest and Berg 
Balance Scale in patients with balance disorders. Physical therapy. Feb 
2013;93(2):158-167. 
129. Smania N, Corato E, Tinazzi M, et al. Effect of balance training on postural instability 
in patients with idiopathic Parkinson's disease. Neurorehabilitation and neural repair. 
Nov-Dec 2010;24(9):826-834. 
130. Tarakci E, Yeldan I, Huseyinsinoglu BE, Zenginler Y, Eraksoy M. Group exercise 
training for balance, functional status, spasticity, fatigue and quality of life in multiple 
sclerosis: a randomized controlled trial. Clinical rehabilitation. Sep 2013;27(9):813-
822. 
131. Harro CC, Shoemaker MJ, Frey O, et al. The effects of speed-dependent treadmill 
training and rhythmic auditory-cued overground walking on balance function, fall 
incidence, and quality of life in individuals with idiopathic Parkinson's disease: a 
randomized controlled trial. NeuroRehabilitation. 2014;34(3):541-556. 
132. Franchignoni F, Horak F, Godi M, Nardone A, Giordano A. Using psychometric 
techniques to improve the Balance Evaluation Systems Test: the mini-BESTest. 
Journal of rehabilitation medicine. Apr 2010;42(4):323-331. 
133. Padgett PK, Jacobs JV, Kasser SL. Is the BESTest at its best? A suggested brief 
version based on interrater reliability, validity, internal consistency, and theoretical 
construct. Physical therapy. Sep 2012;92(9):1197-1207. 
134. King L, Horak F. On the mini-BESTest: scoring and the reporting of total scores. 
Physical therapy. Apr 2013;93(4):571-575. 
135. Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached 
international consensus on taxonomy, terminology, and definitions of measurement 
properties for health-related patient-reported outcomes. Journal of clinical 
epidemiology. Jul 2010;63(7):737-745. 
 76 
136. Stratford P. Reliability: consistency or differentiating among subjects? Physical 
therapy. Apr 1989;69(4):299-300. 
137. Looney MA. When Is the Intraclass Correlation Coefficient Misleading? 
Measurement in Physical Education and Exercise Science. 2000;4(2):73-78. 
138. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness 
of evaluative instruments. Journal of chronic diseases. 1987;40(2):171-178. 
139. Beckerman H, Roebroeck ME, Lankhorst GJ, Becher JG, Bezemer PD, Verbeek AL. 
Smallest real difference, a link between reproducibility and responsiveness. Quality of 
life research : an international journal of quality of life aspects of treatment, care and 
rehabilitation. 2001;10(7):571-578. 
140. Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for 
measurement properties of health status questionnaires. Journal of clinical 
epidemiology. 2007;60(1):34-42. 
141. Borsboom D, Mellenbergh G, van Heerden J. The concept of validity. Psychological 
Review. 2004;111(4):1061-1071. 
142. Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychological 
bulletin. Jul 1955;52(4):281-302. 
143. Allen NE, Sherrington C, Paul SS, Canning CG. Balance and falls in Parkinson's 
disease: a meta-analysis of the effect of exercise and motor training. Movement 
disorders : official journal of the Movement Disorder Society. Aug 1 
2011;26(9):1605-1615. 
144. Conradsson D, Lofgren N, Stahle A, Franzen E. Is highly challenging and progressive 
balance training feasible in older adults with Parkinson's disease? Archives of physical 
medicine and rehabilitation. May 2014;95(5):1000-1003. 
145. Jacobs JV, Horak FB, Tran VK, Nutt JG. Multiple balance tests improve the 
assessment of postural stability in subjects with Parkinson's disease. Journal of 
neurology, neurosurgery, and psychiatry. Mar 2006;77(3):322-326. 
146. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of 
idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of 
neurology, neurosurgery, and psychiatry. Mar 1992;55(3):181-184. 
147. Leddy AL, Crowner BE, Earhart GM. Utility of the Mini-BESTest, BESTest, and 
BESTest sections for balance assessments in individuals with Parkinson disease. 
Journal of neurologic physical therapy : JNPT. Jun 2011;35(2):90-97. 
148. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the 
methodological quality in systematic reviews of studies on measurement properties: a 
scoring system for the COSMIN checklist. Quality of life research : an international 
journal of quality of life aspects of treatment, care and rehabilitation. May 
2012;21(4):651-657. 
149. Duncan RP, Earhart GM. Randomized controlled trial of community-based dancing 
to modify disease progression in Parkinson disease. Neurorehabilitation and neural 
repair. Feb 2012;26(2):132-143. 
150. Poewe W, Rascol O, Sampaio C, Stebbins G. The Unified Parkinson’s Disease Rating 
Scale (UPDRS): Status and Recommendations. Movement Disorders. 
2003;18(7):738-750. 
  77 
151. Nonnekes J, Goselink R, Weerdesteyn V, Bloem BR. The retropulsion test: a good 
evaluation of postural instability in Parkinson's disease? Journal of Parkinson's 
disease. 2015;5(1):43-47. 
152. Fahn S, Elton R. Unified Parkinson's disease rating scale. London: Macmillan; 1987. 
153. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified 
Parkinson's Disease Rating Scale motor examination. Movement disorders : official 
journal of the Movement Disorder Society. Jan 1994;9(1):89-91. 
154. Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo 
F. Unified Parkinson's Disease Rating Scale characteristics and structure. The 
Cooperative Multicentric Group. Movement disorders : official journal of the 
Movement Disorder Society. Jan 1994;9(1):76-83. 
155. Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the 
historical section of the Unified Parkinson's Disease Rating Scale. Movement 
disorders : official journal of the Movement Disorder Society. Mar 1996;11(2):185-
192. 
156. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for 
grading the cognitive state of patients for the clinician. Journal of psychiatric 
research. Nov 1975;12(3):189-198. 
157. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease 
dementia: recommendations from the movement disorder society task force. 
Movement disorders : official journal of the Movement Disorder Society. Dec 
2007;22(16):2314-2324. 
158. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility 
for frail elderly persons. Journal of the American Geriatrics Society. Feb 
1991;39(2):142-148. 
159. Verheyden G, Kampshoff CS, Burnett ME, et al. Psychometric properties of 3 
functional mobility tests for people with Parkinson disease. Physical therapy. Feb 
2014;94(2):230-239. 
160. Nelson AJ, Zwick D, Brody S, et al. The validity of the GaitRite and the Functional 
Ambulation Performance scoring system in the analysis of Parkinson gait. 
NeuroRehabilitation. 2002;17(3):255-262. 
161. Galna B, Lord S, Rochester L. Is gait variability reliable in older adults and 
Parkinson's disease? Towards an optimal testing protocol. Gait & posture. Apr 
2013;37(4):580-585. 
162. Lindemann U, Najafi B, Zijlstra W, et al. Distance to achieve steady state walking 
speed in frail elderly persons. Gait & posture. Jan 2008;27(1):91-96. 
163. Lundin-Olsson L, Nyberg L, Gustafson Y. "Stops walking when talking" as a 
predictor of falls in elderly people. Lancet. Mar 1 1997;349(9052):617. 
164. Brandler TC, Oh-Park M, Wang C, Holtzer R, Verghese J. Walking while talking: 
investigation of alternate forms. Gait & posture. Jan 2012;35(1):164-166. 
165. Verghese J, Buschke H, Viola L, et al. Validity of divided attention tasks in predicting 
falls in older individuals: a preliminary study. Journal of the American Geriatrics 
Society. Sep 2002;50(9):1572-1576. 
 78 
166. Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C. Development and 
initial validation of the Falls Efficacy Scale-International (FES-I). Age and ageing. 
Nov 2005;34(6):614-619. 
167. Jonasson SB, Nilsson MH, Lexell J. Psychometric properties of four fear of falling 
rating scales in people with Parkinson's disease. BMC geriatrics. 2014;14:66. 
168. Kelly LA, McMillan DG, Anderson A, Fippinger M, Fillerup G, Rider J. Validity of 
actigraphs uniaxial and triaxial accelerometers for assessment of physical activity in 
adults in laboratory conditions. BMC medical physics. 2013;13(1):5. 
169. Altman DG. Practical statistics for medical research. London: Chapman & Hall/ 
CRC; 1991. 
170. Hedges L. Distribution Theory for Glass's Estimator of Effect Size and Related 
Estimators Journal of Educational Statistics. 1981;6(2):107-128. 
171. Cohen J. Statistical Power Analysis for the Behavioral Sciences. . Hillsadale: 
Lawrence Erbaum 1988. 
172. Landis JR, Koch GG. The measurement of observer agreement for categorical data. 
Biometrics. Mar 1977;33(1):159-174. 
173. Steiger JH. Tests for Comparing Elements of a Correlation Matrix. Psychological 
bulletin. 1980;87(2):245-251. 
174. Zimmerman DW WR. Properties of the Spearman Correction for attenuation for 
normal and realistic non-normal distributions. Applied Psychological Measurement. 
1997;21(3):253-270. 
175. Spearman C. The proof and measurement of association between two things. 
International journal of epidemiology. Oct 2010;39(5):1137-1150. 
176. Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and 
interpretation. Journal of experimental psychology. General. Feb 2012;141(1):2-18. 
177. Li SC, Huxhold O, Schmiedek F. Aging and attenuated processing robustness. 
Evidence from cognitive and sensorimotor functioning. Gerontology. Jan-Feb 
2004;50(1):28-34. 
178. Burton CL, Strauss E, Hultsch DF, Moll A, Hunter MA. Intraindividual variability as 
a marker of neurological dysfunction: a comparison of Alzheimer's disease and 
Parkinson's disease. Journal of clinical and experimental neuropsychology. Jan 
2006;28(1):67-83. 
179. Gera G, Freeman DL, Blackinton MT, Horak FB, King L. Identification of Balance 
Deficits in People with Parkinson Disease; is the Sensory Organization Test Enough? 
International journal of physical medicine & rehabilitation. Feb 2016;4(1). 
180. Mak MK, Auyeung MM. The mini-BESTest can predict parkinsonian recurrent 
fallers: a 6-month prospective study. Journal of rehabilitation medicine. Jun 
2013;45(6):565-571. 
181. Berg K, Wood-Dauphinée S, Williams J, Gayton D. Measuring balance in the elderly: 
preliminary development of an instrument. Physiotherapy Canada. 1989;41(6):304-
311. 
  79 
182. Tinetti ME. Performance-oriented assessment of mobility problems in elderly 
patients. Journal of the American Geriatrics Society. Feb 1986;34(2):119-126. 
183. Muir SW, Berg K, Chesworth B, Klar N, Speechley M. Quantifying the magnitude of 
risk for balance impairment on falls in community-dwelling older adults: a systematic 
review and meta-analysis. Journal of clinical epidemiology. Apr 2010;63(4):389-406. 
184. Ambrose AF, Cruz L, Paul G. Falls and Fractures: A systematic approach to 
screening and prevention. Maturitas. Sep 2015;82(1):85-93. 
185. Shumway-Cook A, Horak FB. Assessing the influence of sensory interaction of 
balance. Suggestion from the field. Physical therapy. Oct 1986;66(10):1548-1550. 
186. King LA, Priest KC, Salarian A, Pierce D, Horak FB. Comparing the Mini-BESTest 
with the Berg Balance Scale to Evaluate Balance Disorders in Parkinson's Disease. 
Parkinson's disease. 2012;2012:375419. 
187. Wong-Yu IS, Mak MK. Multi-dimensional balance training programme improves 
balance and gait performance in people with Parkinson's disease: A pragmatic 
randomized controlled trial with 12-month follow-up. Parkinsonism & related 
disorders. Jun 2015;21(6):615-621. 
188. Wulf G, Lewthwaite R. Optimizing performance through intrinsic motivation and 
attention for learning: The OPTIMAL theory of motor learning. Psychonomic bulletin 
& review. Jan 29 2016. 
189. Strouwen C, Molenaar EA, Keus SH, et al. Protocol for a randomized comparison of 
integrated versus consecutive dual task practice in Parkinson's disease: the DUALITY 
trial. BMC neurology. 2014;14:61. 
190. Strouwen C, Molenaar EA, Keus SH, et al. Are factors related to dual-task 
performance in people with Parkinson's disease dependent on the type of dual task? 
Parkinsonism & related disorders. Feb 2016;23:23-30. 
191. O'Hoski S, Winship B, Herridge L, et al. Increasing the clinical utility of the 
BESTest, mini-BESTest, and brief-BESTest: normative values in Canadian adults 
who are healthy and aged 50 years or older. Physical therapy. Mar 2014;94(3):334-
342. 
192. Seidler RD, Bo J, Anguera JA. Neurocognitive contributions to motor skill learning: 
the role of working memory. Journal of motor behavior. 2012;44(6):445-453. 
193. King LA, Peterson DS, Mancini M, et al. Do cognitive measures and brain circuitry 
predict outcomes of exercise in Parkinson Disease: a randomized clinical trial. BMC 
neurology. 2015;15:218. 
194. Suresh K. An overview of randomization techniques: An unbiased assessment of 
outcome in clinical research. Journal of human reproductive sciences. Jan 
2011;4(1):8-11. 
195. Efird J. Blocked randomization with randomly selected block sizes. International 
journal of environmental research and public health. Jan 2011;8(1):15-20. 
196. Slack MK, Draugalis JR. Establishing the internal and external validity of 
experimental studies. American journal of health-system pharmacy : AJHP : official 
journal of the American Society of Health-System Pharmacists. Nov 15 
2001;58(22):2173-2181; quiz 2182-2173. 
 80 
197. Aarsland D, Bronnick K, Alves G, et al. The spectrum of neuropsychiatric symptoms 
in patients with early untreated Parkinson's disease. Journal of neurology, 
neurosurgery, and psychiatry. Aug 2009;80(8):928-930. 
198. den Brok MG, van Dalen JW, van Gool WA, Moll van Charante EP, de Bie RM, 
Richard E. Apathy in Parkinson's disease: A systematic review and meta-analysis. 
Movement disorders : official journal of the Movement Disorder Society. May 
2015;30(6):759-769. 
199. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of 
prevalence studies of depression in Parkinson's disease. Movement disorders : official 
journal of the Movement Disorder Society. Jan 30 2008;23(2):183-189; quiz 313. 
200. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G, Norwegian ParkWest 
Study G. Cognitive impairment in incident, untreated Parkinson disease: the 
Norwegian ParkWest study. Neurology. Mar 31 2009;72(13):1121-1126. 
201. Franchignoni F, Godi M, Guglielmetti S, Nardone A, Giordano A. Enhancing the 
usefulness of the Mini-BESTest for measuring dynamic balance: a Rasch validation 
study. European journal of physical and rehabilitation medicine. Aug 
2015;51(4):429-437. 
202. Mehndiratta M, Garg RK, Pandey S. Nonmotor symptom complex of Parkinson's 
disease--an under-recognized entity. The Journal of the Association of Physicians of 
India. May 2011;59:302-308, 313. 
203. Vervoort G, Alaerts K, Bengevoord A, et al. Functional connectivity alterations in the 
motor and fronto-parietal network relate to behavioral heterogeneity in Parkinson's 
disease. Parkinsonism & related disorders. Mar 2016;24:48-55. 
204. Conradsson D. Balance control in older adults with Parkinson's disease- effects of 
medication and exercise, Karolinska Institutet; 2016. 
205. Vidak S, Foisner R. Molecular insights into the premature aging disease progeria. 
Histochemistry and cell biology. Apr 2016;145(4):401-417. 
 
 
